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CHAPTER I. INTRODUCTION 
 
Reduction in functional renal mass 
 
Renal function is critical to life as the kidneys are responsible for filtering wastes, toxins and 
fluids from the blood stream. The ability of the organ to function is a result of the collective 
effort of a number of different types of kidney cells. As shown in Figures 1-1 and 1-2, the outer 
section of the kidney is called the renal cortex and the inner section is called the medulla. The 
kidneys are covered by a layer called the capsule. The nephron, the primary structural unit of the 
kidneys, is comprised of specialized epithelial cells, including those of the glomerulus, proximal 
tubule, the loop of Henle, distal tubules, and collecting duct, each with its own distinctive 
morphology, physiology and biochemistry. Kidney cells display a higher susceptibility to several 
toxicants due to physiological and biochemical reasons (Lash and Cummings, 2010). 
Physiological factors include the fact that the kidneys receive 25% of the cardiac output, which 
ensures that high levels of toxicants are delivered to renal cells. The kidneys also have a 
tremendous ability to concentrate solutes, which results in high concentrations of toxicants in the 
medullary lumen and interstitium. Biochemical factors include the presence of several 
biotransformation enzymes that catalyze the formation of toxic metabolites and reactive 
intermediates such as cytochrome P450 monooxygenases, glutathione S-transferases and flavin-
containing monooxygenases. In addition, the high metabolic rate and workload of renal cells also 
increases their sensitivity to toxicants. 
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It is well known that reductions in functional renal mass occur in humans during aging and 
severe kidney damage from diseases, injuries, infections and congenital conditions and after 
nephrectomy. Nephrectomy, or surgical removal of a kidney or a section of a kidney, is 
performed for treatment of unilateral, secondary renal cancer, infections and for kidney 
transplantation. The incidence of reductions in renal mass is increasing in the U.S. and represents 
a significant challenge to public healthcare. The number of patients treated with dialysis or 
kidney transplantation was projected to increase from 340,000 in 1999 to 651,000 in 2010 
(Holcomb, 2005). Reduction of renal mass due to nephrectomy results in increases in the size 
(hypertrophy) and function of the remnant kidney cells, most prominently in the proximal tubular 
(PT) region (Meyer et al., 1996), and this multistep adaptive process is called compensatory 
renal hypertrophy. 
 
Studies have shown that surgical removal of one kidney in experimental animals and patients 
was performed in the nineteenth century and led to the observation that the remaining kidney 
subsequently undergoes compensatory renal growth (Nowinski, 1969). In adult animals, 80% of 
compensatory renal growth following uninephrectomy is reportedly due to hypertrophy, an 
increase in cell size predominantly of proximal tubules, whereas 15-30% of growth can be 
ascribed to hyperplasia, an increase in cell number (Johnson and Vera, 1966; Johnson, 1969). 
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Figure 1-1. Kidney Structure. 
From Campbell and Reece (2005). 
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Figure 1-2. From blood filtrate to urine: A closer look. 
From Campbell and Reece (2005). 
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Compensatory renal hypertrophy: Cellular and molecular events underlying compensatory 
renal hypertrophy 
Although the phenomenon of compensatory renal hypertrophy is well known and despite 
extensive research over the past century, the mechanism of this process still remains unclear. 
After the removal of one kidney, the remaining kidney exhibits a hyperfiltration state and 
changes in glomerular hemodynamics that activate a series of growth events leading to 
compensatory growth of the remaining kidney (Wesson, 1989; Fine and Norman, 1992). This 
compensatory hypertrophy response is mediated by vasoactive molecules, cytokines, growth 
factors and increases in glomerular capillary pressure and flow (Holcomb, 2005; Meyer et al., 
1996; Fine, 1986; Shirley and Walter, 1991). 
 
The cellular characteristics of hypertrophy include increases in cellular volume, area and surface 
density of the basolateral (BLM) and brush-border plasma membranes (BBM), increases in 
cellular synthesis and content of glutathione (L-γ-glutamyl-L-cysteinyl-glycine, GSH) (Zalups 
and Lash, 1990), and mitochondrial proliferation within renal PT cells (Johnson and Amendola, 
1969). Physiological changes consist of increased glomerular filtration rate (GFR), renal blood 
flow (RBF) and water and electrolyte transport (Shirley and Walter, 1991; Wolf and Neilson, 
1991; Zalups and Henderson, 1992). Biochemical changes include increases in renal protein 
content (Coe and Korty, 1967; Halliburton and Thomson, 1967), rates of renal protein synthesis 
(Johnson and Vera Roman, 1966) and RNA synthesis (Johnson and Vera Roman, 1966; 
Ouellette, 1983) and increased mitochondrial metabolism in proximal and distal tubules (Harris 
et al., 1988; Nath et al., 1990; Shapiro et al., 1994). 
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Additionally, activities of most renal enzymes increase in the hypertrophied kidney. For 
example, increased activity of enzymes that are involved in excretion of solutes, such as the 
(Na
+
+K
+
)-stimulated ATPase (Mujais and Kurtzman, 1986; Scherzer et al., 1985) and enzymes 
that contribute to cell growth, such as ornithine decarboxylase (Brandt et al., 1972; Humphreys 
et al., 1988), guanylate cyclase, protein kinase C, enzymes of the pentose phosphate pathway 
(Schlondorff and Weber, 1976; Caramelo et al., 1988; Steer et al., 1982), choline kinase and 
choline phosphotransferase (Toback et al., 1974; Hise et al., 1984), are observed. 
 
The sequential production of different growth factors is also required to achieve coordinated 
growth of kidney cells after growth has been triggered by some unidentified kidney-specific 
signal. There is also strong evidence that a large number of factors promote kidney growth in 
cultured PT cells, including insulin, insulin-like growth factor (IGF-1), epidermal growth factor 
(EGF), hepatocyte growth factor (HGF), platelet-derived growth factor, prostaglandin E2, and 
hormones including hydrocortisone, thyroxine, arginine vasopressin and angiotensin (Fine, 1986; 
Caramelo et al., 1988; Igawa et al., 1991). Moreover, recent studies suggest that transforming 
growth factor-  (TGF- ) is one of the most important factors causing tubular cell hypertrophy 
(Franch et al., 1995; Fujita et al., 2004; Wolf et al., 1993; Sinuani et al., 2006). TGF-  induces 
hypertrophy of tubular cells through a cell cycle-dependent mechanism that involves entry of 
cells into the G1 phase, initiating G1-related events, and arresting cell cycle progression prior to 
the G1/S restriction point (Franch et al., 1995, 1997; Nagahara et al., 1999). 
 
The toxicological implications of compensatory renal growth are higher susceptibility to 
nephrotoxicants such as inorganic mercury, analgesics and cadmium metallothionein (Henry et 
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al., 1983; Houser and Berndt, 1986; Lash and Zalups, 1992; Lash et al., 1999, 2006; Molland, 
1976; Zalups, 1997; Zalups and Diamond, 1987; Zalups et al., 1992). Furthermore, previous 
studies from our lab showed that cellular GSH content was significantly higher in renal 
homogenates (whole kidney, cortex and outer stripe of the outer medulla) from 
uninephrectomized (NPX) rats, suggesting that increased GSH content is an adaptive response to 
enhanced oxidative stress (Zalups and Lash, 1990). 
 
It has been further shown that there are many factors that influence the compensatory renal 
growth response. For example, feeding a protein-rich diet increased kidney weight in NPX rats 
(Hostetter et al., 1986), administration of androgens increased kidney weight in mice and rats 
(Schlondorff et al., 1977; Blantz et al., 1988), and a greater growth response after 
uninephrectomy was observed in young rats as compared to older rats (Barrows et al., 1962). 
Conversely, starvation, protein depletion and endocrine abnormalities retard growth (Hayslet, 
1979). 
 
Compensatory renal hypertrophy, mitochondria, nephrotoxicity and clinical complications 
The mitochondria are the primary organelle for production of ATP. Reducing equivalents from 
malate and glycerol phosphate are transported from the cytoplasm into mitochondria by the 
NADH shuttle system. Pyruvate, which is a product of glycolysis, enters mitochondria and is 
metabolized by the citric acid cycle to produce NADH and FADH2. NADH and FADH2 further 
go through the electron-transport chain located on the inner mitochondrial membrane to 
synthesize ATP. The electron-transport chain consists of four enzyme complexes, denoted as 
complexes I, II, III and IV. Complex I is the NADH:ubiquinone oxidoreductase. Complex II is 
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the succinate:ubiquinone oxidoreductase. Complex III is the ubiquinol:cytochrome c 
oxidoreductase, which is a ubisemiquinone radical-generating Q cycle and can be a site at which 
1% to 2% of total oxygen consumption leaks to generate superoxide anion (O2
.-
). Complex IV is 
the cytochrome c oxidase.   
 
Under normal conditions, mitochondrial reactive oxygen species (ROS) produced in the course 
of metabolism are contained by the natural antioxidant system that protects cells from ROS-
mediated modifications. The main mitochondrial antioxidants are GSH, manganese superoxide 
dismutase and thioredoxin systems. The antioxidant capacity of mitochondria is limited 
compared to the cytoplasm and mitochondria depend on GSH transporters for their GSH supply. 
The various antioxidants play a crucial role in protection from oxidative stress, which can be 
caused by an increase in ROS or an impaired antioxidant defense system. Under various 
abnormal conditions, the rate of ROS production may exceed the natural antioxidant capacity, 
leading to oxidative stress. The primary ROS produced in the course of mitochondrial oxygen 
metabolism is superoxide anion, which is a highly reactive and cytotoxic ROS. 
 
Mitochondria are not only the main organelle that produces superoxide anion but are also the 
main targets of ROS, leading to mitochondrial dysfunction. It has been shown that compensatory 
renal hypertrophy results in increased energy demands on PT cells. To accommodate these 
energy demands, there are increased rates of mitochondrial electron transport, which produces a 
hypermetabolic state (Harris et al., 1988; Shapiro et al., 1994) that can lead to mitochondrial 
dysfunction. In addition, our previous studies also showed in isolated mitochondria from 
hypertrophied PT cells that although intramitochondrial GSH contents and activity are increased, 
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these mitochondria exhibit an enhanced basal oxidative stress and greater sensitivity to 
mitochondrial toxicants (Lash et al., 2001a). There is increasing evidence that in experimental 
animals, compensatory renal hypertrophy increases risk for later toxicological complications due 
to increased renal oxidative stress. For example, uninephrectomy and compensatory renal 
hypertrophy result in markedly altered susceptibility to injury from a broad variety of 
nephrotoxicants, including heavy metals, analgesics, and antibiotics (Zalups et al., 1992; Lash 
and Zalups, 1992; Lash et al., 1999, 2006; Molland, 1976; Zalups, 1997; Zalups and Diamond, 
1987). 
 
There is also strong evidence in experimental animals that significant reduction in renal mass 
leads to proteinuria, systemic and glomerular hypertension, glomerular hyperfiltration and 
progressive renal damage (Hostetter et al., 2001; Remuzzi et al., 2006; Santos et al., 2006). 
Studies also suggest this glomerular hypertension and glomerular hyperfiltration lead to 
pathogenesis of proteinuria and progressive glomerulosclerosis (Hostetter et al., 2001). Ever 
since the recognition of hyperfiltration injury in animals undergoing renal ablation, there has 
been concern over the extended outcome after kidney donation. There is also strong clinical 
evidence that suggests short and long-term medical risks of human renal donor nephrectomy for 
transplantation purposes. The human clinical studies that investigated the quality of life of renal 
donors found early and late health complications such as hypertension, microalbumiuria, 
hematuria and proteinuria (Azar et al., 2007; Berber et al., 2008). 
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Function and importance of thiol redox status in renal function in proximal tubules 
Due to high rates of aerobic metabolism in the proximal tubules and high exposure to a broad 
and diverse range of chemicals and drugs, the kidneys are highly dependent on adequate supply 
of the thiol-disulfide redox protectant GSH to maintain proper function. Besides the GSH 
system, there are other renal protective systems, including thioredoxin and low-molecular-weight 
thiols such as N-acetyl-L-cysteine (NAC) (Lash, 2010). Several signaling pathways also function 
in nephroprotection, such as the epidermal growth factor (EGF), mitogen activated protein kinase 
(MAPK), protein kinase B (PKB/Akt), protein kinase C (PKC), heat shock proteins (HSPs), and 
nuclear factor kappa-B (NF-ĸB) pathways; these act through modulation of redox status or by 
altering cellular pH (Lash, 2010). Small amino acids, such as glycine, are also nephroprotective. 
 
GSH is the most abundant non-protein thiol (SH) in mammalian cells. As shown in Figure 1-3, 
GSH is a tripeptide composed of the amino acids L-glutamate, L-cysteine and glycine. 
Glutathione can exist in two major forms: the antioxidant „reduced glutathione‟ tripeptide is 
called glutathione and abbreviated GSH; the oxidized form is a sulfur-sulfur linked compound 
known as glutathione disulfide or GSSG (Kidd, 1997). The GSH/GSSG ratio may be a sensitive 
indicator of oxidative stress. The high electron-donating capacity of GSH due to its sulfhydryl (-
SH) group combined with its high intracellular concentration endow GSH with great reducing 
power, which is used to regulate a complex thiol-exchange system (Franco, 2007). Glutathione is 
present inside cells mainly in its reduced GSH form. Intracellular GSH status appears to be a 
sensitive indicator of the overall health of the cell and of its ability to resist toxic challenges. 
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As shown in Figure 1-4, the primary, critical processes involving GSH are peroxide reduction, 
electrophile conjugation, glutathionylation and action as a coenzyme in detoxification, 
metabolism and hormone biosynthesis. GSH is considered the most important antioxidant in the 
human body. GSH recycles other antioxidants, such as vitamins A, C and E, keeping them in an 
active state longer and helping to prevent oxidative stress and inflammation. GSH is often called 
„the master antioxidant.‟ GSH acts as a main detoxifier by binding to toxins such as heavy 
metals, solvents and pesticides, allowing them to be excreted in urine or bile. GSH strengthens 
the immune system by boosting production of T cells that fight viral and bacterial infections. 
Elevated GSH levels help the body to produce more white blood cells. White blood cells are the 
most important cells for maintaining sterility of body fluids by serving as garbage collectors for 
the body. In other words, healthy growth and activity of white blood cells depend on availability 
of GSH. It is widely accepted that GSH also acts as a mediator of many other physiological 
reactions, including cellular signaling, metabolism of xenobiotics, thiol-disulfide exchange 
reactions, and as an important reservoir of cysteine (Franco, 2007). 
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Figure 1-3. Glutathione (GSH) structure. 
The L-glutamyl and L-cysteinyl residues are linked through the -carboxyl group of L-glutamate, 
making the isopeptide bond resistant to most proteases. The tripeptide thiol glutathione (GSH) 
has facile electron-donating capacity, linked to its sulfhydryl (–SH) group. 
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Figure 1-4. Functions of glutathione (GSH). 
The basic types of functions for GSH in cytoprotection are mentioned. 
Abbreviations: E, electrophile; GLRX, glutaredoxin; GPX, GSH peroxidase; GRD, glutathione 
disulfide reductase; GS–R, GSH conjugate; GSSG, glutathione disulfide; PRX, peroxiredoxin; 
ROH, lipid alcohol; ROOH, lipid peroxide. 
From Lash (2010). 
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As shown in Figure 1-5, GSH is synthesized in the cytoplasm by two ATP-dependent reactions, 
the glutamate-cysteine ligase (GCL) [also called γ-glutamyl cysteine synthetase (γ-GCS)] and 
GSH synthetase (GS). In the first reaction, L-cysteine and L-glutamate are combined by -
glutamyl cysteinyl synthetase. In the second reaction, GSH synthetase combines -glutamyl-
cysteine with glycine to generate GSH. Reduced glutathione (GSH) is oxidized to glutathione 
disulfide (GSSG) in a reaction catalyzed by glutathione peroxidase and GSSG is reduced to 
regenerate GSH by glutathione reductase, which uses NADPH as a hydrogen donor. GSH 
degradation is mediated by either a hydrolysis or transpeptidation reaction catalyzed by -
glutamyltransferase (GGT), followed by hydrolysis catalyzed by dipeptidase (DP) activity. The 
major difference between synthesis and degradation is that whereas degradation occurs 
extracellularly, as both GGT and DP face the external side of the BBM and GGT is selectively 
localized on the BBM, GSH synthesis occurs in the cytoplasm as GCL and GS are found 
exclusively in the cytoplasm. 
 
The highest concentration of GSH is found in the liver, which is the principal organ involved in 
the detoxification and elimination of toxic materials. As shown in Figure 1-6, the process by 
which GSH circulates throughout the body, which involves transport across plasma membranes 
and translocation between tissues, is called „Interorgan metabolism‟ (Anderson et al., 1980; 
Griffith and Meister, 1979a; Lash et al., 1988; McIntyre and Curthoys, 1980). Hepatic GSH is 
transported out of the liver by transport across either the sinusoidal or canalicular plasma 
membranes to plasma and bile, respectively (Ballatori and Dutczak, 1994; Kaplowitz et al., 
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1985). Biliary GSH is degraded to constituent amino acids in either the bile or small intestine 
and the enterohepatic circulation returns these amino acids to the liver for resynthesis of GSH. 
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Figure 1-5. Glutathione Synthesis. 
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Figure 1-6. Interorgan transport and metabolism of GSH. 
This scheme summarizes the pathways for transport, translocation between tissues and 
metabolism of GSH and its metabolites involving the liver, kidneys, small intestine, bile and 
plasma. 
Abbreviations: BBM, brush-border membrane; BLM, basolateral membrane; CM, canalicular 
membrane; SM, sinusoidal membrane. 
From: Lash (2010). 
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Plasma GSH is extracted by the kidneys by either glomerular filtration or basolateral uptake. 
Even though liver is the primary source of GSH, the kidneys (predominantly PT cells) are the 
major site for metabolism of GSH in the body. The kidneys play a central role in the overall 
disposition of GSH in the body. Whereas the liver exhibits low activities of GSH uptake and 
GGT for degradation of GSH, the kidneys play the major role in uptake and efflux of GSH, 
synthesis of GSH from precursors, degradation of GSH and uptake of constituent amino acids 
(Lash et al., 1988). The kidneys extract approximately 80% of the plasma GSH pool during a 
single pass of the blood through the renal circulation (Griffith and Meister, 1979a; Haberle et al., 
1979). As shown in Figure 1-7, 50% of the GSH extracted occurs by a basolateral route whereas 
30% of the extraction occurs by glomerular filtration. 
 
Pathways of glutathione transport in renal proximal tubule 
 
Plasma membrane GSH transport systems: Basolateral membrane (BLM) and brush 
border membrane (BBM) transport 
 
Basolateral plasma membrane transport: Renal PT cells obtain GSH from both extracellular 
spaces by transport across the BLM and intracellular synthesis from precursor amino acids. 
 
GSH uptake across the BLM of renal PT cells comprises two transport processes, a Na
+
-coupled 
and a Na
+
-ion independent pathway. Current data suggest the potential involvement of three 
carriers in the transport of GSH across the BLM of renal PT cells, the organic anion transporter 1 
(Oat1; Slc22a6), organic anion transporter 3 (Oat3; Slc22a8), and the sodium-dicarboxylate 
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carrier 3 (NaC3; Slc13a3; formerly known as sodium-dicarboxylate transporter 2 or SDCT-2). 
As described in Figure 1-8, Oat1 and Oat3 function in the uptake of GSH in exchange for 2-
oxoglutarate (2-OG
2-
) and NaC3 functions in the co-transport of GSH with at least two Na
+
 ions. 
Both Oat1 and Oat3 are broad-substrate specific organic anion transporters that are highly 
expressed on the renal BLM. The functions of Oat1 and Oat3 account for the sodium-
independent uptake of GSH (Lash and Jones, 1983, 1984; Lash et al., 2007) and that of NaC3 
accounts for the sodium-coupled uptake of GSH across the renal BLM. The (Na
+
+K
+
)-stimulated 
ATPase provides the Na
+
 ion gradient for transporters such as NaC3, thereby helping to provide 
the driving force for uptake of GSH and other organic anions. Two multidrug resistance proteins, 
Mrp5 (Abcc5) and Mrp6 (Abcc6), function in the ATP-dependent efflux of organic anions. In 
addition to organic anion transporters, there are also organic cation transporters, such as Oct2 
(Slc22a3) and Oct3 (Slc22a3) present on the BLM. Both Oct2 and Oct3 are uniporters for uptake 
of organic cations (OC
+
). 
 
Brush border plasma membrane transport: As shown in Figure 1-8, unlike BLM GSH transport, 
the BBM process is not mediated by coupling to transport of any ion such as protons or Na
+
 ions 
and is predominantly efflux of intracellular GSH into the tubular lumen rather than uptake of 
extracellular GSH into the cell. At the outer surface of the BBM, GSH is rapidly degraded to its 
constituent amino acids such as cysteine, which is the rate-limiting component. Cysteine is taken 
up by carriers on the BBM and is used for protein or GSH synthesis. 
 
Although no direct evidence for a role for any specific carrier in the efflux of GSH across the 
BBM has been demonstrated, the proposed carriers as mediators of GSH efflux are the organic  
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Figure 1-7. Pathways for GSH transport and metabolism in renal proximal tubular cells. 
Abbreviations: Cys, cysteine; DIC, dicarboxylate carrier; GCS, g-glutamylcysteine synthetase; 
GSH, glutathione; GS, GSH synthetase; Oat1/3, organic anion transporters 1 and 3; DIC, 
dicarboxylate carrier; OGC, oxoglutarate carrier. 
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Figure 1-8. Schematic summary of renal plasma membrane transporters. 
Major transporters for the uptake or efflux of OA
–
 or OC
+
 on the BLM and BBM of PT cells are 
illustrated. There are also the (Na
+
+K
+
)-ATPase on the BLM and NHE on the BBM, which 
provide ion or co-substrate gradients. 
Abbreviations: BLM, basolateral membrane; BBM, brush-border membrane; Oat, organic anion 
transporter; Mrp, multidrug resistance protein; Oct, organic cation transporter; Oat-k1/k2, kidney 
specific organic anion transporter; NHE, sodium-hydrogen exchanger; GS
–
, Thiolate anion of 
glutathione; OA
–
, organic anion; OC
+
, organic cation; 2-OG
2–
, 2-oxoglutarate; NaC3, sodium-
coupled carboxylate transporter; Oatp1, organic anion transporting polypeptide 1. 
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anion transporting polypeptide 1 (Oatp1; Slco1a1) and two isoforms of the ATP-dependent 
multidrug resistance proteins, Mrp2 (Abcc2) and Mrp4 (Abcc4). As described in Figure 1-8, 
Oatp1, which is highly expressed on the BBM of the rat proximal tubule, has been shown in 
other systems to mediate the efflux of GSH (Li et al., 1998; Mittur et al., 2002) and both Mrp2 
and Mrp4 have been demonstrated to transport GSH (Evers et al., 2000; Gotoh et al., 2000; Lou 
et al., 2003; Paulusma et al., 1999; Rebbeor et al., 2002 Rius et al., 2003). The BBM also 
expresses three major carriers that function in the secretion of organic cations (OC
+
): Octn1 
(Slc22a4), Octn2 (Slc22a5) and P-glycoprotein [P-gp]. Octn1 is an electroneutral exchanger of 
OC
+
 with protons. Octn2 can function in either the facilitated efflux of OC
+
 or as a Na
+
 
ion/carnitine uptake cotransporter. 
 
Significance of BLM and BBM GSH transport: Based on pharmacological and toxicological 
studies, there are several potential functions for GSH transport across renal plasma membranes. 
Previous studies provided in vivo evidence for renal tissue GSH uptake by orally administered 
GSH (Aw et al., 1991; Flagg et al., 1994; Hagen et al., 1990). In addition, in vitro studies with 
isolated renal PT cells showed that exogenous GSH increases intracellular GSH levels by BLM 
transport and protected against various oxidants (Hagen et al., 1988; Lash and Tokarz, 1990; 
Lash et al., 1996), suggesting significance of BLM GSH uptake in nephroprotection against 
toxicants. 
 
Even though there is some uncertainty in the literature regarding the precise physiological 
function of GSH uptake across the renal BLM, the critical physiological importance of GSH 
efflux across the renal BBM has been long appreciated (Lash, 2005, 2009). The BBM GSH 
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transport process is critical for turnover of whole body GSH as efflux of GSH into the lumen 
mediates delivery of GSH to the active site of GGT on the surface of the BBM. The transport of 
GSH across the BBM occurs with favorable driving forces including an outwardly-directly GSH 
electrochemical gradient and high GGT activity on the BBM. Furthermore, previous studies 
showed that inhibition of renal GGT activity in mice causes glutathionuria, suggesting the 
importance of BBM efflux and GGT activity in GSH turnover (Griffith and Meister, 1979b). 
 
Mitochondrial GSH status, transporters, and mechanisms of renal mitochondrial GSH 
transport 
There are two main cellular pools of GSH, one in the cytoplasm and the other in mitochondria 
(Franco, 2007). The pH of cytoplasm is approximately 7.0 and that of the mitochondrial matrix is 
approximately 7.8. Hence, the GSH pools are likely to each have a net charge of between -1 and 
-2. As shown in Figure 1-9, GSH is synthesized in the cytoplasm and the predominant, if not 
exclusive, location of enzymes catalyzing synthesis of GSH is the cytoplasm, suggesting that the 
transport of GSH from the cytoplasm to mitochondria must occur to supply mitochondria with 
GSH. We have shown previously that renal concentrations of GSH increase significantly after 
uninephrectomy (Zalups and Lash, 1990). Because mitochondria lack enzymes for the synthesis 
of GSH, what may cause an increase in mitochondrial GSH in PT cells from NPX rats? We 
attempted to answer this question in two ways: First, by measuring rates of synthesis of GSH in 
the cytoplasm and second, by measuring rates of transport of GSH from cytoplasm into 
mitochondria. Our data showed that GCS activity was significantly higher in PT cells from NPX 
rats than in PT cells from SHAM-operated (or control) rats (Lash and Zalups, 1994). These data 
suggest that compensatory renal growth causes increases in the intracellular concentration of 
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GSH by inducing synthesis from its precursors by GCS, which is the rate-limiting enzyme 
involved in GSH biosynthesis. After the synthesis of GSH in cytoplasm, GSH is then transported 
across the mitochondrial inner membrane into the matrix. 
 
Mitochondria possess a membrane potential with the matrix space negative relative to the 
cytoplasm and GSH is a negatively charged molecule at physiological pH. These facts suggest 
that GSH must be transported actively or in exchange for another anion by mitochondrial anion 
carriers. There are eight known anion carriers present in the mitochondrial inner membrane that 
could play a role in the uptake of GSH from the cytoplasm (Table 1-1). These carriers are highly 
active in cells such as those of the renal proximal tubule because of high rates of mitochondrial 
respiration, active transport and gluconeogenesis (Lash, 2006). These mitochondrial carriers are 
electroneutral in the sense that they mediate exchange of anions so that there is no net transfer of 
charge across the inner mitochondrial membrane. Substrate specificity and energy dependence 
studies in isolated rat kidney mitochondria (McKernan et al., 1991; Chen and Lash, 1998) 
showed that two electroneutral anion exchange carriers, the dicarboxylate carrier (DIC, 
Slc25a10) and 2-oxoglutarate carrier (OGC, Slc25a11) mediate most of the GSH uptake into 
mitochondria. The function of each of these carriers is electroneutral, catalyzing the exchange of 
anions across the inner membrane without any net transfer of charge. Furthermore, at least 80% 
of GSH transport across the inner membrane of kidney mitochondria is due to the function of the 
DIC and OGC (Chen and Lash, 1998, Chen et al., 2000). The function of these carriers in 
transport of citric acid cycle intermediates suggests further that mitochondrial GSH status is 
regulated by mitochondrial energetics. 
 
25 
 
 
 
 
Figure 1-9. Mitochondrial GSH content and transport. 
DIC, Dicarboxylate carrier; GS
–
, thiolate anion of glutathione; 2-OG
2–
, 2-oxoglutarate; OGC, 
oxoglutarate carrier; Pi
2-
, inorganic phosphate. 
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Table 1-1. Mitochondrial anion transporters. 
From Lash (2006). 
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A generalized scheme illustrating the functions of the DIC and OGC in GSH transport and their 
relationship to both the citric acid and GSH redox cycles is shown in Figure 1-9. These two 
carriers mediate the electroneutral exchange of GSH (in the form of GS
2–
) with inorganic 
phosphate and 2-OG, respectively. As both carriers are also involved in the transport of citric 
acid cycle intermediates, amino acids and gluconeogenesis precursors (Klingenberg 1979; 
Palmieri, 2004; Palmieri et al., 1996), this indicates that mitochondrial GSH status is influenced 
by mitochondrial energy status. Both the DIC and OGC belong to a superfamily of mitochondrial 
inner membrane transporters with similar three-dimensional structures as predicted by the 
TMpred program. According to data from the TMpred program, the members of this superfamily 
have three trans-membrane domains (TMDs). Each TMD is composed of two hydrophobic 
stretches that span the membrane as α-helices, each separated by hydrophilic loops. Both the N- 
and C-terminals are in the cytoplasm. Both DIC and OGC are similar in size, with the DIC 
containing 286 or 287 amino acids with a molecular weight of ~31 kDa and the OGC containing 
314 to 322 amino acids with a molecular weight of 34-37 kDa, depending on species. 
 
Significance of mitochondrial GSH transport in protection from oxidative stress 
Mitochondria maintain redox balance and serve as the primary intracellular sites of generation of 
reactive oxygen species (ROS). The redox status of mitochondrial GSH is known to be critical 
for proper mitochondrial function. Alterations in GSH concentration and redox status are 
associated with oxidative stress induced by peroxides and other oxidants in mitochondria from 
kidney, liver, brain, tumor cells and activation of signaling pathways. In addition, previous 
studies have shown that decreased concentration of mitochondrial GSH is associated with acute 
toxicity (Lash and Anders, 1987) and apoptosis (Chen et al., 2001) in renal mitochondria and 
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renal PT cells and depletion of the mitochondrial pool of GSH leads to several types of chemical-
induced toxicity such as oxidative stress (Shan et al., 1993; Fernandez-Checa et al., 1993). Thus, 
maintenance of adequate concentrations of GSH within the mitochondrial matrix is essential for 
regulation and proper function of many critical processes. 
 
To explore the physiological and toxicological importance of mitochondrial GSH transport in a 
well-defined renal cellular model system, the influence of modulation of mitochondrial GSH 
status on cellular function and susceptibility to toxicants was studied in NRK-52E cells, an 
immortalized cell line derived from normal rat kidney (Lash et al., 2002a). Our previous studies 
showed that two mitochondrial carriers, the DIC and OGC, are responsible for at least 80% of 
total transport of cytoplasmic GSH across the renal mitochondrial membrane (Chen and Lash, 
1998; Chen et al., 2000). To further explore the role of these two carriers in GSH transport, 
NRK-52E cells were transfected with cDNA for rat DIC, OGC and a double-cysteine mutant of 
the OGC (Xu et al., 2006; Lash et al., 2002b). Overexpression of the DIC or OGC resulted in 
5.5-fold and 6.1-fold increases in rates of mitochondrial GSH transport, respectively, as 
compared to wild-type cells. In contrast, cells overexpressing the mutant OGC exhibited a 
marked reduction in GSH transport as compared to wild-type cells. 
 
To investigate the toxicological consequences of alterations in mitochondrial GSH transport, 
NRK-52E cells were transfected with either nothing (WT) or cDNAs for the rDIC, rOGC or 
rOGC-Mutant (Xu et al., 2006; Lash et al., 2002b). NRK-52E cells were incubated with either of 
two mitochondrial toxicants, 10 µM tert-butyl hydroperoxide (tBH) and 50 µM S-(1,2-
dichlorovinyl)-L-cysteine (DCVC), to determine the fraction of cells undergoing apoptosis. 
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Although both tBH and DCVC exhibit distinct mechanisms of action, both can cause lipid 
peroxidation, GSH oxidation in mitochondria and apoptosis under appropriate conditions (Lash 
et al., 2001a). The results showed that NRK-52E-DIC or NRK-52E-OGC cells exhibited 
resistance to cell injury whereas NRK-52E-OGC-M cells exhibited similar sensitivity to tBH or 
DCVC as the NRK-52E-WT cells. These results suggest that higher GSH transport activity by 
overexpression of DIC and OGC markedly protected against apoptosis induced by either DCVC 
or tBH, indicating the significance of mitochondrial GSH transport in determining susceptibility 
to cytotoxic chemicals. 
 
Goals of present study 
Compensatory renal hypertrophy caused by a reduction in functional renal mass is associated 
with a series of physiological, morphological and biochemical changes that also have 
toxicological implications. As mentioned above, human clinical data also suggest health 
complications due to reduced renal mass caused by renal donor nephrectomy. One of the 
simplest experimental models for compensatory renal hypertrophy is the uninephrectomy rat 
model (NPX model). In this NPX rat model, the right kidney is removed and compensatory renal 
hypertrophy response is completed within 7-10 days and is maintained for at least 30 days 
thereafter. 
 
Previous studies showed that compensatory renal hypertrophy increases energy demand on PT 
cells by increasing oxygen consumption and glucose production, leading to a hypermetabolic 
state (Harris et al., 1988) that is associated with alterations in renal function and mitochondrial 
status. Furthermore, previous studies showed that increased renal GSH content (Zalups and Lash, 
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1990) and higher susceptibility to nephrotoxicants (Lash et al., 2006) follow nephrectomy. These 
observations suggest that increased renal GSH content is an adaptive response to an enhanced 
basal oxidative stress that results from compensatory renal hypertrophy and susceptibility to 
oxidant-induced injury increases because the increase in renal GSH content is insufficient to 
maintain redox balance in the hypertrophied kidney cells. Interestingly, in 2002 and 2006 our lab 
also showed that in NRK-52E cells, overexpression of mitochondrial GSH transporters protected 
against nephrotoxicants (Lash et al., 2002b; Xu et al., 2006). These data suggested a possibility 
that this approach can be used to protect hypertrophied kidney cells by further increasing renal 
mitochondrial GSH content. Based on all these previous studies, we hypothesize that 
compensatory renal hypertrophy after uninephrectomy alters renal function in vivo and 
mitochondrial status. Further, we hypothesize that modulation of mitochondrial redox status 
alters susceptibility to nephrotoxicants and oxidative stress in hypertrophied kidney cells. To 
study these hypotheses, three specific aims of this study were conducted: 
 
Aim 1. Determine the effect of compensatory renal hypertrophy on renal function including 
physiological parameters and renal plasma membrane transporters. 
 
Aim 2. Determine the effect of compensatory renal hypertrophy on mitochondrial status 
including mitochondrial redox status, function, energetics, oxidative stress, size, number and 
membrane potential. 
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Aim 3. Manipulation of mitochondrial glutathione (GSH) by overexpression of mitochondrial 
GSH carriers, DIC and OGC, to provide sustained increases in mitochondrial GSH content and 
reduce susceptibility to nephrotoxicants in hypertrophied kidney cells. 
 
Studies in Aim 1 and Aim 2 were conducted in vivo, in vitro and ex vivo to study renal function 
and mitochondrial status. Studies in Aim 3 were done ex vivo using a primary cell culture model 
with molecular approaches to study the effect of mitochondrial redox status on susceptibility of 
PT cells to nephrotoxicants. In the nephron, glomerular and proximal tubular epithelium are the 
most prominent sites that exhibit the various morphological, biochemical and functional changes 
seen after uninephrectomy and compensatory renal growth. Our studies focus on the PT cells 
because these cells play a major role in metabolite absorption and secretion and drug 
metabolism. As a result, these PT cells are also a major target cells for drug-induced 
nephrotoxicity and are most prominently affected in acute renal failure. Even though there are 
numerous parameters of toxicity, changes in mitochondrial energetics and redox status appear to 
be prominent components of the compensatory renal hypertrophy response. Hence, we primarily 
focused on mitochondrial function and redox status. 
 
Overall, our proposed research plan provides integrated approaches with in vivo, in vitro and ex 
vivo models to further study renal function and mitochondrial energetics status, including redox 
status and oxidative stress, and the influence of mitochondrial GSH on susceptibility to 
chemically induced cytotoxicity. The significance of the present study lies in the occurrence of 
reduction in functional kidney mass due to numerous diseases, surgery, aging and substantial 
evidence that compensatory renal hypertrophy also increases the risks for development of health 
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complications, renal insufficiency or renal failure from other diseases or environmental 
exposures. 
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CHAPTER II. MATERIALS AND METHODS 
 
Animals 
Surgical Procedures. Male Sprague-Dawley rats (150-175g) were used in the present study. 
Animals that underwent surgical nephrectomy (removal of right kidney) were allowed a 
minimum 10-day recovery period prior to experiments (Zalups and Lash, 1990). Right-side 
nephrectomized rats were purchased from Harlan (Indianapolis, IN). The procedure they used is 
as follows: Each rat was anesthetized with sodium pentobarbital (50 mg/kg i.p.) before surgery. 
Unilateral nephrectomy was performed by making a 2.5-cm flank incision on the right side of the 
body with a No. 11 scalpel blade, beginning at erector spinae muscles and continuing along the 
angle of the 12
th
 rib. The incision was made through the skin and underlying fascia. The 
abdominal muscles were then incised along the same plane as the skin was cut to expose the 
retroperitoneal region where the right kidney is situated. With blunt dissection, the right kidney 
was exteriorized from the animal and the renal blood vessels and ureter were ligated with sterile 
2.0 silk suture. The right kidney was then excised distal to the ligature. The abdominal muscles 
were sewn together with 4.0 sterile silk suture and the opposite ends of the incised skin and 
fascia were brought together with sterile 9-mm would clips. Control rats were surgically naïve, 
because previous studies showed that sham surgery has no apparent effect on the compensatory 
growth response (Zalups and Lash, 1990; Zalups, 1997; Lash et al., 1999). Control and NPX rats 
were age-matched for all studies. 
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Uninephrectomized Rat Model  
In the uninephrectomized rat (NPX) model, the right kidney is removed and the compensatory 
hypertrophy response is completed within 7-10 days after surgery (Zalups and Diamond, 1987; 
Meyer et al., 1996). The experiments are done between day 10 and 30.  
 
II-1 RENAL FUNCTION AND MITOCHONDRIAL STATUS 
Chemicals 
Cis-parinaric acid was purchased from Molecular Probes (Eugene, OR). Rotenone, tert-butyl 
hydroperoxide (tBH), hemin and 1-methyl-2-phenylindole were purchased from Sigma-Aldrich 
(St. Louis, MO). All other chemicals were of the highest purity available and were purchased 
from commercial sources. 
 
Methods 
 
In vivo assessment of renal physiological parameters 
Rats were kept in metabolic cages and urine samples were collected every 24 h for one week. 
Basic parameters of renal function, including urine volume (U-Vol), urinary protein (U-Pr), 
urinary-glutathione (U-GSH) and urinary glutathione disulfide (U-GSSG), urinary and serum 
creatinine (U-Cr, S-Cr), urinary albumin (U-Alb), urinary N-acetyl- -D-glucosaminidase (U-
NAG) and urinary -glutamyltransferase (U-GGT) were measured. 
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U-Pr (BCA protein assay kit from Pierce, Milwaukee, WI, U.S.A.), U-Cr and S-Cr 
(Quantichrom
TM
 creatinine kit from BioAssay Systems, Hayward, CA, U.S.A.), U-Alb (Nephrat 
ii kit from Exocell, Philadelphia, PA, U.S.A.), U-GSH and U-GSSG (GSH-Glo® kit from 
Promega, Madison, WI, U.S.A.), and U-NAG (NAG assay kit from Diazyme, Poway, CA, 
U.S.A.) were measured using commercial kits. U-GGT was measured by a spectrophotometric 
assay (Orlowski and Meister, 1963). 
 
Determination of protein expression of renal plasma membrane organic anion transporters 
by Western blot analysis 
Crude plasma membrane fractions were isolated according to the method of Scalera et al. (1981) 
using a sucrose-triethanolamine (0.25 mM sucrose, 10 mM triethanolamine/HCl, pH 7.6, 0.1 mM 
phenylmethylsulfonyl fluoride) buffer. Protein expression of organic anion transporters was 
determined in isolated plasma membranes from kidney cortex derived from control and NPX rats 
using commercially prepared antibodies. Polyclonal antibodies to organic anion transporter 1 and 
3 (Oat1 and Oat3; Slc22a6 and Slc22a8, respectively) were purchased from Alpha Diagnostic 
International (San Antonio, TX, U.S.A.). Monoclonal antibodies against multidrug resistance-
associated protein 2 and 5 (Mrp2 and Mrp5; Abcc2 and Abcc5, respectively) were purchased 
from Abcam (Cambridge, MA, U.S.A.). Monoclonal antibody against Na
+
K
+
ATPase 1 subunit 
was purchased from Affinity Bioreagents, Inc. (Golden, CO, U.S.A.). Secondary antibodies 
(anti-rat, anti-rabbit, and anti-mouse) were purchased from Jackson ImmunoResearch (West 
Grove, PA, U.S.A.). Polyclonal anti-actin antibody was purchased from Cell Signaling 
Technology (Danvers, MA, U.S.A.) for use as a control for loading of total cellular protein. 
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Determination of protein expression of renal mitochondrial GSH transporters and redox 
status proteins by Western blot analysis 
Suspensions of isolated mitochondria were prepared from renal cortex from control and NPX 
rats by differential centrifugation as follows: Rat kidneys were decapsulated and the medulla 
removed. Kidneys were then placed in 15 ml of ice-cold buffer (225 mM sucrose, 10 mM 
potassium phosphate, pH 7.4, 5 mM MgCl2, 20 mM KCl, 20 mM triethanolamine, pH 7.4, 0.1 
mM phenylmethylsulfonyl fluoride, and 2 mM EGTA), homogenized, and centrifuged in 50 ml 
polycarbonate centrifuge tubes at 600 x g (2250 rpm) for 10 min in a Sorvall SS34 rotor in a 
Sorvall RC2B centrifuge. Supernatant was decanted and saved. The pellets containing tissue 
fragments and mitochondria were washed with 30 ml of buffer and the resuspended material 
centrifuged at 600 x g for 10 min. The supernatant fractions were combined and centrifuged at 
15,000 x g for 5 min. The resultant pellet was resuspended in 2 ml of buffer without EGTA. 
Protein expression of mitochondrial GSH transporters and redox enzymes were determined in 
isolated mitochondria with commercially prepared antibodies. Specific proteins were visualized 
by Enhanced Chemiluminescence (Pierce; Rockford, IL, U.S.A.). Monoclonal antibodies against 
the 2-oxoglutarate carrier (OGC; Slc25a11) and prohibitin and polyclonal antibodies against the 
dicarboxylate carrier (DIC; Slc25a10), superoxide dismutase 2 (Sod2) and the voltage-dependent 
anion channel (VDAC or porin) were purchased from Abcam (Cambridge, MA, U.S.A.). 
Polyclonal antibody against thioredoxin 2 (Trx2) was purchased from Santa Cruz Biotechnology 
(Santa Cruz, CA, U.S.A.). Expression of VDAC or prohibitin was used as mitochondrial loading 
controls. 
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Analysis of gene expression by real-time PCR 
Total RNA from the renal cortex was isolated using Trizol® (Invitrogen; Carlsbad, CA, U.S.A.). 
First-strand cDNA was made from the isolated total RNA using a multiscribe reverse 
transcriptase with random hexamers from Applied Biosystems (Foster City, CA, U.S.A.). 
TaqMan Gene Assay kits containing primer/probe sets for Oat1 (GenBank accession no. 
NM_017224), Oat3 (GenBank accession no. NM_031332), DIC (GenBank accession no. 
NM_133418), OGC (GenBank accession no. NM_022398), and glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH; loading control; GenBank accession no. NM_017008.3) were 
purchased from Applied Biosystems. All reactions were performed in triplicate. The relative 
amounts of mRNA were calculated by using the comparative CT method. 
 
Determination of mitochondrial GSH status 
A fluorometric method (Hissin and Hilf, 1976) was used for determination of GSH and GSSG in 
mitochondrial suspensions. GSH content was measured by the fluorescent product formed on 
reaction with o-phthalaldehyde (OPT) with excitation at 350 nm and emission at 420 nm. GSSG 
content was measured after treatment with N-ethylmaleimide, followed by reduction with 
dithiothreitol and measurement of the fluorescent product formed with OPT. 
 
Enzyme assays and protein determination 
Activities of several GSH- and energy metabolism-related enzymes were measured in cytoplasm 
and/or mitochondria from renal cortical homogenates from control and NPX rats. 
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GSSG reductase assay: 
GSSG reductase (GRD) activity was measured as NADPH oxidation by monitoring the decrease 
in absorbance at 340 nm (ε = 6,220 M-1cm-1) as described by Bellomo et al. (1987). 
 
GSH peroxidase assay: 
GSH peroxidase (GPX) activity was measured with 25 mM H2O2 as substrate and was equated to 
NADPH oxidation as detected by the decrease in absorbance at 340 nm (ε = 6,220 M-1cm-1) 
according to Lawrence and Burk (1976). 
 
GSH S-transferase assay: 
GSH S-transferase (GST) activity was measured with 1-chloro-2,4-dinitrobenzene as substrate 
and quantitation of S-2,4-dinitrophenyl-GSH formation by the increase in absorbance at 340 nm 
(ε = 9,600 M-1cm-1) as described by Habig et al. (1974). 
 
Glutamate dehydrogenase assay: 
Glutamate dehydrogenase (GDH) activity was measured spectrophotometrically by coupling 2-
oxoglutarate reduction to NADH oxidation as described by Schmidt and Schmidt (1983). The 
oxidation of NADH was coupled to the reduction of 2-oxoglutarate to glutamate according to the 
following reaction: 
2-oxoglutarate + NADH + NH4  glutamate + NAD
+
 + H2O 
The activity was quantified by determining the consequent decrease in absorbance at 340 nm 
using an extinction coefficient of 6,220 M
-1
cm
-1
 for NADH. 
39 
 
 
 
 
 
Malic dehydrogenase assay: 
Malic dehydrogenase (MDH) activity was measured as described by Ochoa (1955). The 
oxidation of NADH was coupled to the reduction of oxaloacetate to malate according to the 
following reaction: 
Oxaloacetate + NADH + H
+
   L-Malate + NAD
+ 
The activity was determined by monitoring the decrease in absorbance at 340 nm (ε = 6,220 M-
1
cm
-1
). 
 
Succinate: cytochrome c oxidoreductase assay: 
Succinate: cytochrome c oxidoreductase (SDH) activity was measured as described by Fleischer 
and Fleischer (1967). The oxidation of succinate to fumarate was coupled to reduction of 
ferricytochrome c to ferrocytochrome c according to the following reaction: 
Succinate + 2- ferricytochrome c  fumarate + 2-ferrocytochrome c 
The activity was quantified by determining the increase in absorbance at 550.5 nm using an 
extinction coefficient of 18,500 M
-1
cm
-1
 for reduced cytochrome c. 
 
Protein Determination:  
Protein content of samples was determined by the bicinchoninic acid (BCA) protein assay 
method using bovine serum albumin as a standard (Bradford, 1976). 
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Mitochondrial oxygen consumption 
Oxygen consumption was measured in suspensions of isolated renal cortical mitochondria from 
control and NPX rats with a Gilson 5/6H Oxygraph in a thermostated, air-tight, 1.6 ml chamber 
at 25˚C (Lash et al., 2001a). State 3 rates of oxygen consumption were measured by the addition 
of 0.3 mM ADP and respiratory substrate (3.3 mM succinate in the presence of 5 μM rotenone) 
for coupling site II to the chamber containing 0.5 ml of mitochondrial sample and 1 ml 
mitochondrial buffer. State 4 rates of oxygen consumption were measured after depletion of 
ADP. Respiratory control ratio (RCR = State 3/State 4) was then calculated. 
 
Mitochondrial Proteomics 
Two mitochondrial samples of renal cortical homogenates from control and NPX rat group were 
used. An aliquot (100 µg) of each mitochondrial extract was reduced with DTT, alkylated with 
iodoacetamide and digested with trypsin overnight at 37˚C. Each of the samples was labeled with 
a unique isobaric iTRAQ tag (Applied Biosystems): Control-114 (tag), NPX-115 (tag). The 
samples were combined and purified by strong cation exchange chromatography using the SCX 
Methods Development Kit (Applied Biosystems). Each sample was dried and resuspended in 
water (2 cycles), then dried and resuspended in 2% acetonitrile, 0.1% TFA. 
 
Peptides were separated by reverse phase chromatography (Magic C18 column, Michrom). 
Peptides were ionized with the ADVANCE ion source (Michrom) and introduced into a LTQ-
XL mass spectrometer (Thermo Fisher Scientific). Abundant species were fragmented in Pulsed-
Q Dissociation mode (PQD). 5 LC/MS/MS runs were performed, 3 short and 2 long, on the same 
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sample. Data analyses were performed twice using SEQUEST, X!Tandem and Mascot search 
engines. A rat protein database (IPI ver 3.47) was used for the analysis. 
 
Relative quantitation:  
115/114: average signal intensity (NPX) / average signal intensity (Control) 
 
The proteomics work was done at the Proteomics Core Facility of the Institute of Environmental 
Health Sciences at Wayne State University, School of Medicine. 
 
Assessment of basal and toxicant-induced mitochondrial oxidative stress 
 
Lipid peroxidation by malondialdehyde assay 
One method for assessment of lipid peroxidation was measurement of malondialdehyde (MDA) 
formation using 1-methyl-2-phenylindole (Gérard-Monnier et al., 1998). Mitochondrial 
suspensions (200 μl) were treated with tBH (500 μM) or buffer for 1 h at 37˚C and then 
hydrolyzed using 0.1 M HCl and incubated for 60 min at 60˚C. An aliquot (200 μl) of the 
resulting supernatant was then incubated with 650 μl 1-methyl-2-phenylindole and 150 μl 37% 
HCl. After incubating the mixture for 30 min at 45˚C, absorbance at 586 nm was determined. 
 
Lipid peroxidation by cis-parinaric acid fluorescence assay 
Cis-parinaric acid is considered a very sensitive marker for the initial stages of lipid peroxidation 
(Tribble et al., 1994). Isolated mitochondria (1 mg protein/ml) were incubated on ice with 6.4 
μM cis-parinaric acid for 15 min. After pelleting mitochondria (11,200 g x 5 min) and discarding 
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the supernatant, mitochondria were resuspended (0.5 mg protein/ml) in mitochondrial buffer. For 
anaerobic conditions, mitochondria were resuspended in mitochondrial buffer (prepared with 
nitrogen sparging) and treated with 5 μM hemin (Fe2+). Samples were then added to a 24-well 
plate and incubated at room temperature for 10 min before treatment with tBH or buffer. Lipid 
peroxidation was measured as the loss of cis-parinaric acid fluorescence (excitation 324 nm, 
emission 413 nm) over time using a fluorescence plate reader (Tribble et al., 1994; Murphy et al., 
2003). 
 
Mitochondrial aconitase activity 
Aconitase activity was assayed by following formation of NADPH at 340 nm at 25˚C, as 
described by Han et al. (2003). The reaction mixture contained 30 mM Tris-HCl, pH 7.4, 30 mM 
sodium citrate, 0.6 mM MnCl2, 0.2 mM NADP
+
, 1 U/ml isocitrate dehydrogenase and 0.1 mg of 
mitochondrial protein. 
 
Analysis of oxidative stress markers by Western blot analysis 
Proteins modified with 3-nitrotyrosine (3-NT) or 4-hydroxy-2-nonenal (HNE) were also assessed 
as markers of oxidative alterations in renal mitochondria. Monoclonal antibody to 3-NT was 
purchased from Abcam (Cambridge, MA, U.S.A.). Polyclonal antibody to HNE was purchased 
from Calbiochem (La Jolla, CA, U.S.A.). 
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Effect of toxicant (tBH) on mitochondrial protein expression during compensatory renal 
hypertrophy  
Mitochondrial samples from control and NPX groups were treated with 10 µM tBH for 1h at 
37
o
C. Each of the samples was labeled with a unique isobaric iTRAQ tag (Applied Biosystems): 
Control-116 (tag), NPX-117 (tag). The samples were processed as described previously in the 
mitochondrial proteomics section.  
 
Relative quantitation: 
117/115: average signal intensity (NPX-tBH) / average signal intensity (NPX) 
116/114: average signal intensity (Control-tBH) / average signal intensity (Control) 
117/116: average signal intensity (NPX-tBH) / average signal intensity (Control-tBH) 
 
Data analysis 
Data for enzyme assays were normalized to the content of cellular protein. All measurements 
were performed at least 3 to 5 times. Results are expressed as means ± SEM unless specified. 
Densitometry of bands on Western blots were performed using GelEval 1.22 software for Mac 
OS X. When two or more parameters were varied and compared (e.g., tBH treatment vs. buffer 
in control and NPX rats), significant differences among means for data were first assessed by a 
one-way analysis of variance. When significant “F values” were obtained, the Fisher‟s protected 
least significance t test was performed to determine which means were significantly different 
from one another, with two-tail probabilities < 0.05 considered significant. Otherwise, Student‟s 
t-test was performed to determine which means were significantly different from one another, 
using a two-tail probability of P < 0.05 as the criteria for significance. 
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II-2 STUDIES IN PROXIMAL TUBULAR CELL PRIMARY CULTURES 
 
Chemicals 
Percoll, collagenase (type I; EC 3.4.24.3), type I collagen, bovine serum albumin (fraction V), 
penicillin G, streptomycin, amphotericin B, insulin (from bovine pancreas), human transferrin, 
sodium selenite, hydrocortisone, epidermal growth factor (EGF; from mouse submaxillary 
glands), and 3,3‟,5-triiodo-DL-thyronine (T3) were purchased from Sigma Chemical Co. (St. 
Louis, MO). Dulbecco‟s modified Eagle‟s medium/Ham‟s F-12 (DMEM/F-12, 50/50, 1X) was 
purchased from Mediatech Inc. (Herndon, VA). Polystyrene tissue culture dishes were purchased 
from Corning Inc. (Corning, NY). Polypropylene micromesh (210 µm pore size) was purchased 
from SpectraPor Inc. (Rancho Dominguez, CA). 
 
Culture of rat proximal tubular cells 
Isolated renal cortical cells were obtained by collagenase perfusion (Jones et al., 1979). A day 
before perfusion, all the glassware and surgical tools were sterilized in an autoclave. On the day 
of perfusion, Hank‟s concentrate (5X) containing 137 mM NaCl, 5.4 mM KCl, 0.81 mM 
MgSO4.7H2O, 0.42 mM Na2HPO4, 0.44 mM KH2PO4 and 25 mM NaHCO3 was used to make 
Hank‟s I (25 mM Hepes, 0.5 mM EGTA and 2% (w/v) BSA) and Hank‟s II (4 mM CaCl2 and 
0.15% (w/v) collagenase) buffers. Krebs-Henseleit Concentrate #1 (2X) containing 118 mM 
NaCl, 4.8 mM KCl, 0.96 mM KH2PO4, 1.2 mM MgSO4.7H2O, 25 mM NaHCO3 and 2.55 mM 
CaCl2.2H2O was used to make KHB-1 buffer. Krebs-Henseleit Concentrate #2 (10X) containing 
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118 mM NaCl, 4.8 mM KCl, 0.96 mM KH2PO4, 1.2 mM MgSO4.7H2O and 25 mM NaHCO3 
and 25 mM Hepes was used to make KHB-II buffer. All buffers were bubbled with 95% O2/5% 
CO2 for 30 min and adjusted to pH 7.40. 
 
Rats were anaesthetized with an intraperitoneal injection of sodium pentobarbital (50 mg/kg 
body weight) and injected with 0.3 ml heparin into the tail vein. After sterilizing abdominal walls 
with 70% (v/v) ethanol, the peritoneal cavity was opened by a midventral incision and the aorta 
was freed below and above the renal arteries. One ligature with 4-O silk was placed below the 
renal arteries and a second one was placed right below the liver. To avoid leakage of the 
perfusion fluid, mesenteric arteries (coeliac and superior) are ligated. A small incision is made in 
the aorta above the lower ligature and a 19-gauge conical probe cannula is inserted and closed 
with a clamp and a ligature. The perfusion of kidneys is started in situ using Hank‟s I buffer 
maintained at 37
˚C. Once kidneys become pale, Hank‟s I buffer is replaced by Hank‟s II buffer 
maintained at 37˚C. After a few minutes of perfusion, the kidneys are excised from the posterior 
abdominal wall and transferred to beaker containing Hank‟s II buffer. 
 
After circulating the buffer for 20 min at a flow rate of 5 ml/min, the kidneys are dispersed with 
a pair of forceps into KHB-1 buffer containing 25 mM Hepes and 2% (w/v) BSA. The digested 
renal mixtures were filtered through a 210 m polypropylene micromesh from SpectraPor Inc. 
(Rancho Dominguez, CA), and then the filtrates were centrifuged for 2 min at 50 rpm at room 
temperature. The pellets were resuspended in KHB-II buffer and 5 ml of cortical cells were 
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layered on 35 ml of Percoll solution in 50-ml polycarbonate centrifuge tubes. After centrifuging 
both tubes at 4
˚
C for 30 min at 12,900 rpm in a SS34 rotor in a Sorvall RC2B centrifuge, the 
upper layers of cells, which are PT cells, were taken out. The PT cells were diluted with 
DMEM/F-12 (50/50, 1X) media supplemented with 5 µg/ml insulin, 100 ng/ml Hydrocortisone, 
100 ng/ml EGF, 5 µg/ml transferrin, 30 nM sodium selenite, 7.5 pg/ml triidothyronine, 100x 
antibiotics (penicillin, streptomycin and amphotericin B). The cells were seeded onto collagen-
coated, 35-mm polystyrene tissue culture dishes at a density of 2 to 4 x 10
6
 cells/ml. Media were 
changed the next day and every other day thereafter. On day 4 of culture, the cells were 
processed. 
 
MitoTracker
TM
 orange staining 
On day 4 of primary culture, the PT cells were stained with MitoTracker
TM
 orange (50 nM) for 
30 min. The cells were viewed with a Zeiss LSM-510 META NLO Laser Scanning Confocal 
Microscope at 554 nm excitation and 576 nm emission using 630x magnification. Three images 
of each group were quantitated by using Metamorph 7.1.7.0 Offline (Molecular Devices, 
Sunnyvale, CA) with measurement of integrated intensity of the entire image. Average intensity 
(intensity/µm) of three confocal images from each group was then calculated. 
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JC-1 (5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzyimidazolyl-carbocyanine iodide) 
staining 
On day 4 of primary culture, PT cells were stained with JC-1 (5 µg/ml) for 30 min. The cells 
were analyzed with a LSM-510 META NLO Laser Scanning Confocal Microscope using an 
overlay of images in red (488 nm excitation, 590 nm emission, polarization) and green (488 nm 
excitation, 525 nm emission, depolarization) using 630x magnification. Three images of each 
group were quantitated by using Metamorph 7.1.7.0 Offline (Molecular Devices, Sunnyvale, 
CA) with measurement of integrated intensity of the entire image. Average intensity 
(intensity/µm) of three confocal images from each group was then calculated. 
 
Confocal Microscopy 
The confocal work was done at the Microscopy, Imaging and Cytometry Resources Core at 
Wayne State University, School of Medicine (Detroit, MI). 
 
DNA fluorescence assay 
DNA was purified from renal mitochondria from control and NPX rats using the SV genomic 
DNA purification system (Promega, Madison WI). Mitochondrial DNA was measured by a DNA 
fluorescence assay (Sorger and Germinario, 1983). Relative fluorescence of the DNA-DAPI 
complex was measured with a SpectraMax M2 plate reader set to 360 nm excitation and 450 nm 
emission. A concentrated DAPI stock solution (1 mg/ml in water) was wrapped in foil and stored 
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at 0-4˚C. A DAPI working solution (2.5 µg/ml) was prepared by bringing 1 ml of DAPI stock 
solution (1 mg/ml) to 400 ml with assay buffer (18 mM Na2SO4 in 50 mM Hepes, pH 7.0). 
 
Standards were prepared containing 0.25-2.5 µg DNA/ml, 200 µg BSA/ml and 10 µl/ml of 1 M 
NaOH in 0.2% Triton X-100. Aliquots of standards and mitochondrial samples were added to 
disposable glass tubes and 2.5 ml of DAPI reagent (0.4 volumes of DAPI working solution (2.5 
µg/ml), 3.6 volumes of assay buffer, 6 volumes of water) was added to each tube. After 90 min 
of incubation at room temperature, relative fluorescence was measured. 
 
Mitochondrial protein assay 
Protein content of renal mitochondrial samples was determined by the bicinchoninic acid (BCA) 
protein assay method using bovine serum albumin as a standard (Pierce Rockford, IL). 
 
Transfection 
DIC cDNA that was cloned into pcDNA 3.1/V5-His-TOPO vector (Lash et al., 2002b) and 
cDNA encoding OGC that was cloned into pcDNA 3.1/V5-His-TOPO vector (Xu et al., 2006) 
were purified using Maxiprep (Promega, Madison WI). 
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On day 3 of primary culture, cells were transfected with purified DIC and OGC plasmids with 
final concentration of 800 ng plasmid DNA/well of Dulbecco‟s modified Eagle‟s medium using 
Lipofectamine
TM
 and PLUS
TM
 reagents (Invitrogen; Carlsbad, CA, U.S.A.). 
 
Gene expression by real-time PCR 
Total RNA was isolated on day 6 of cell culture (72 h post-DIC transfection) from cell culture of 
rat PT cells using Trizol
®
 (Invitrogen; Carlsbad, CA, U.S.A.). First-strand cDNA was made from 
the isolated total RNA using a multiscribe reverse transcriptase with random hexamers from 
Applied Biosystems (Foster City, CA, U.S.A.). Taq Man gene assay kits containing primer/probe 
sets for DIC (GenBank accession no. NM 133418), OGC (GenBank accession no. NM 022398) 
and glyceraldehyde 3-phosphate dehydrogenase (GAPDH, GenBank accession no. NM 
017008.3) were purchased from Applied Biosystems. The fold change of genes was calculated 
by the 2
∆CT 
formula where 2 is used assuming a doubling in every cycle. 
 
Assay for assessment of cytotoxicity 
Necrotic cell death was measured in PT cells by measurement of lactate dehydrogenase (LDH) 
release. On day 6, suspensions of PT cells were treated with either antimycin A (1 µM, 10 µM), 
tBH (100 µM, 200 µM) or MVK (100 µM, 200 µM) for 4 h with or without an overnight 
preincubation with 5 mM GSH. After 4 h, aliquots were removed and LDH activity was 
measured. LDH activities in supernatant and cells were measured spectrophotometrically as 
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NADH oxidation at 340 nm after addition of 3 mg/ml pyruvate and 3 mg/ml NADH. Percentage 
of LDH release was calculated using the formula: 
% LDH release = [LDH activity in media/(LDH activity in media + LDH activity in cells)] x 
100% 
 
Data analysis 
Results are expressed as means ± SE values of measurements from the indicated number of cell 
preparations. Significant differences among selected mean values were calculated using 
Student‟s t-test with P values ≤ 0.05 as the criteria for significance.  
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CHAPTER III.  RENAL FUNCTION 
 
Renal physiological parameters in vivo 
 
Results 
Examination of basic parameters of renal function indicates that there are some discernable 
changes in rats post-nephrectomy compared to age-matched control rats (Table 3-1). After 
uninephrectomy and a 10-day period to allow for completion of the acute phase of compensatory 
growth, the remaining kidney weighs significantly more than a single kidney from control rats. 
NPX animals had markedly higher urine volume, indicating an increase in renal function to 
compensate for the loss of a kidney. However, we also observed increases in total urinary protein 
(U-Pr), urinary albumin (UAlb), serum creatinine (S-Cr), urinary N-acetyl- -D-glucosaminidase 
(U-NAG), urinary -glutamyltransferase (U-GGT) and urinary glutathione disulfide (U-GSSG), 
but lower urinary creatinine (U-Cr) over a 24-h period and lower creatinine clearance (CCr), 
indicating significant impairment of renal function. 
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Table 3-1. Physiological parameters of renal function in vivo.  
Parameters were measured in uninephrectomized (NPX) rats at 10 days post-surgery and in age-
matched control rats. Results are means ± SEM of measurements from the indicated number of 
rats from each group. 
 
Parameter (units; n) Control NPX 
Kidney Weight (g; 10) 0.95 ± 0.04 1.51 ± 0.06* 
U-Vol (ml; 6)          3.08 ± 0.47 8.43 ± 1.63* 
U-Pr (mg/24 h; 6)   11.1 ± 1.5 34.9 ± 3.2* 
S-Cr (mg/dl; 3) 0.09 ± 0.04 0.24 ± 0.06* 
U-Cr (mg/dl; 3) 168 ± 7 93.6 ± 11.2* 
U-Cr (mg/24 h; 3) 7.63 ± 0.48 5.43 ± 0.30* 
CCr (ml/min; 3) 6.67 ± 0.80 2.00 ± 0.54* 
U-Alb (mg/24 h; 3) 150 ± 10 860 ± 110* 
U-GSSG (nmol/24 h; 6) 1.53 ± 0.73 9.51 ± 0.32* 
U-NAG (U/24 h; 9) 0.07 ± 0.01 0.14 ± 0.03* 
U-GGT (mU/24 h; 6) 197 ± 9 327 ± 30* 
 
Abbreviations: U-Vol, urinary volume; U-Pr, urinary protein; S-Cr, serum creatinine; U-Cr, 
urinary creatinine; CCr, creatinine clearance; U-Alb, urinary albumin; U-GSSG, urinary 
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glutathione disulfide; U-NAG, urinary N-acetyl- -D-glucosaminidase; U-GGT, urinary -
glutamyltransferase. *Significantly different (P<0.05) from the corresponding value in control 
rats. 
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Discussion 
The major underlying hypothesis to explain the physiological and pathological changes that 
occur in remnant renal tissue as a consequence of compensatory renal hypertrophy begins with 
the increased need for renal function requiring increased mitochondrial electron transport to 
generate ATP (Meyer et al., 1996; Harris et al., 1988; Nath et al., 1990; Shapiro et al., 1994). As 
a consequence of this increase in mitochondrial function, more reactive oxygen species are 
generated, which in turn leads to a higher level of renal oxidative stress, further leading to 
increased susceptibility of renal PT cells from NPX rats to nephrotoxicants. 
 
The present study not only confirmed the increase in kidney weight and urine production that 
accompany the compensatory response of the remnant kidney after uninephrectomy, but also 
provided evidence at the in vivo level that this compensation is associated with some degree of 
renal damage. Several markers, which are all considered diagnostic for renal function, were 
uniformly altered in a manner consistent with mild renal injury. Evidence for renal injury at the 
level of the PT cell was also observed by the increases in U-NAG and U-GGT. We also observed 
a 6.2-fold increase in U-GSSG, which may indicate some amount of oxidative damage in the 
kidneys. Compared to normal conditions in which creatinine is filtered and proteins usually do 
not cross the glomerular membrane, compensatory renal hypertrophy decreases creatinine 
clearance but increases protein secretion. Previous studies have shown that proteinuria is also 
correlated with intrinsic renal toxicity and contributes to progression of renal damage (Bertani et 
al., 1986). The compensatory renal hypertrophy also decreases the ability to conserve ions, 
bicarbonate and water, leading to increases in urine volume. This suggests increased renal 
function to compensate for the reduction in nephron mass. 
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Our data are also consistent with previous animal studies that suggested that glomerular 
hypertension and glomerular hyperfiltration lead to pathogenesis of proteinuria and progressive 
glomerulosclerosis (Hostetler et al., 2001). Overall, our data also suggest some clinical 
implications such as proteinuria, microalbuminuria and hypertension, which is consistent with 
data from human clinical studies that are investigating the quality of life of renal transplant 
donors (Berber et al., 2008; Tellioglu et al., 2008; Azar et al., 2007). 
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Protein and gene expression analysis of renal plasma membrane organic anion 
transporters. 
 
Results 
Based on previous observations of increases in intracellular GSH concentrations and GSH 
transport activity after compensatory renal hypertrophy (Zalups and Lash, 1990; Lash et al., 
2001b), we hypothesized that these increases were due, at least in part, to increases in gene 
and/or protein expression of carriers involved in GSH transport across renal plasma membranes. 
To test this, we determined mRNA and protein expression of four renal plasma membrane 
transporters that are known or thought to be involved in GSH transport. Real-time PCR analysis 
of Oat1 and Oat3 mRNA expression (Table 3-2) revealed no differences between control and 
NPX rats. In contrast, Western blot analyses of Oat1 and Oat3 protein levels showed nearly 2-
fold increases in protein expression for both carriers in kidneys of NPX rats as compared to those 
of control rats (Figure 3-1). 
 
Additionally, expression of two Mrp carriers that can transport GSH were examined. Whereas 
protein expression of Mrp2, which is localized to the BBM, was increased by approximately 
30% in NPX rat kidneys as compared to that in control rat kidneys, expression of Mrp5, which is 
localized to the BLM, was unchanged. Inasmuch as both Oat1 and Oat3 are believed to mediate 
uptake of GSH into the renal PT cell whereas both Mrp2 and Mrp5 mediate efflux from the cell, 
the larger increase in Oat1/3 compared to that for Mrp2 are consistent with higher intracellular 
accumulation of GSH. We also examined protein expression of the (Na
+
 + K
+
)-ATPase, which 
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provides the major driving force for many secondary active transport carriers; its expression was 
also found to be significantly higher (1.4-fold) in kidneys of NPX rats as well. 
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Figure 3-1. Effect of compensatory renal growth on protein expression of renal plasma 
membrane organic anion transporters and the (Na
+
 + K
+
)-stimulated ATPase.  
Protein expression of Oat1, Oat3, Mrp2, Mrp5 and the (Na
+
 + K
+
)-stimulated ATPase were 
determined by Western blot analysis as described in Section 2. -Actin protein was used as a 
loading control. Blots were scanned and quantified by densitometry using GelEval 1.22 software. 
Data represent means ± SEM of measurements from renal homogenates from three control and 
three NPX rats. *Significantly different (P < 0.05) from corresponding control sample. 
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Table 3-2. Real-time quantitative PCR analysis of Oat1, Oat3 mRNA expression in renal 
cortex of control and NPX rats. 
Primers were designed with the aid of Oligo 6.76 and the cDNA sequences published in 
GenBank
TM
. Primer and labeled probe sets were from Applied Biosystems. An optimum cDNA 
concentration of 30–300 ng DNA/well was determined for each gene. All CT values are based on 
the measurements of total RNA samples from kidney cortex of both control and NPX rats and 
are means ± SEM. GAPDH CT values were used for correction: For Oat1 and Oat3 samples, 
GAPDH CT values = 30.3 ± 0.2 for control rats and 30.4 ± 0.3 for NPX rats. Relative gene 
expression values were calculated by the formula: 2
-∆CT (NPX)
 / 2
-∆CT (Control), ∆CT value is the 
difference between the CT value for the gene of interest and that of GAPDH.     
   
 
 
 
Gene  Control 
CT mean ± SE 
NPX 
CT mean ± SE 
Relative Expression 
(NPX / Control) 
Oat 1 (Slc22a6) 31.4 ± 0.3 32.0 ± 0.8 0.75 
Oat 3 (Slc22a8) 32.4 ± 0.1 32.8 ± 0.5 0.86 
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Discussion 
A longstanding observation is that compensatory renal hypertrophy is associated with a 
significant increase in total cellular GSH content compared to that in kidneys from control rats, 
particularly in the PT region of the nephron (Zalups and Lash, 1990). We previously showed that 
compensatory renal hypertrophy is associated with higher activity of -glutamylcysteine 
synthetase (GCS) (Lash and Zalups, 1992, 1994; Lash et al., 2001b). While higher GCS activity 
could certainly be one mechanism for the increase in the cytoplasmic pool of GSH, increased 
transport across the BLM of plasma or renal periplasma GSH is also another potential 
mechanism. Thus, increase in the activity and/or expression of the plasma membrane carrier 
proteins that are responsible for GSH transport into the PT cell may also help explain some of 
the data. 
 
Despite the lack of a clear understanding of the physiological role(s) for uptake of GSH into the 
renal PT cell, several candidate carrier proteins have been identified (Lash, 2005, 2009; Lash et 
al., 2007). These include Oat1, Oat3, and the sodium-dicarboxylate 3 (NaC3; Slc13a3) carriers 
on the renal BLM. Additionally, both Mrp2 and Mrp5 can mediate efflux of GSH out of the renal 
PT cell across the BBM and BLM, respectively. The present study demonstrated significantly 
higher protein expression (~ 2-fold increases) for both Oat1 and Oat3 in renal homogenates from 
NPX rats. Whereas no difference was observed between Mrp5 expression in renal homogenates 
from control and NPX rats, Mrp2 protein expression was modestly (~ 50%) higher in renal tissue 
from NPX rats. Thus, although there is higher efflux by Mrp2, the increases in uptake by Oat1 
and Oat3 would seem to predominate, thereby leading to higher intracellular accumulation of 
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GSH. These results are consistent with our previous finding of higher activity of both Oat1 and 
Oat3 in renal BLM vesicles from NPX rats as compared to those from control rats (Lash et al., 
2005). 
 
Expression of these Oat carriers at the mRNA level was also determined by real-time PCR. 
Despite our expectation that mRNA levels of the Oat carriers would be higher in kidneys of NPX 
rats, we found no differences between kidneys of the two groups of rats. This indicates that the 
changes in the plasma membrane carriers that occur as a consequence of compensatory renal 
growth are post-transcriptional and/or post-translational, and probably involve a combination of 
effects, including increased mRNA translation, increased protein stability, and/or decreased 
protein degradation. 
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CHAPTER IV.  MITOCHONDRIAL STATUS 
Mitochondrial redox status 
 
Results 
To determine whether or not compensatory renal hypertrophy causes alterations in renal 
mitochondrial redox status, we first measured mitochondrial GSH (reduced glutathione) and 
GSSG (glutathione disulfide) levels in renal mitochondria from both control and NPX rats. 
Modest, but significant increases were observed in concentrations of both GSH and GSSG in 
renal mitochondria from NPX rats as compared to those from control rats (Table 4-1). 
 
Inasmuch as GSH status in renal mitochondria is determined primarily, if not entirely, by the 
function of two inner membrane carrier proteins, the DIC and OGC (Chen and Lash, 1998; Chen 
et al., 2000), we next determined gene and protein expression of these carriers. Because previous 
work (Lash et al., 2001a) showed markedly higher rates of GSH uptake by renal mitochondria 
from NPX rats as compared to those from control rats, we expected to see increases in 
expression of these carrier proteins. Despite this expectation, neither mRNA (Table 4-2) nor 
protein (Figure 4-1) expression of either the DIC or OGC were elevated in renal mitochondria 
from NPX rats as compared to those in renal mitochondria from control rats. Besides the GSH 
system, redox status in mitochondria is also regulated by two other enzymes, superoxide 
dismutase 2 (Sod2) and thioredoxin 2 (Trx2). Measurements of protein expression of Sod2 and 
Trx2 (Figure 4-2), however, showed no significant differences between renal mitochondria of 
control and NPX rats. 
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Table 4-1. GSH and GSSG concentrations in renal mitochondria from control and NPX 
rats. 
Mitochondrial GSH and GSSG levels were measured in suspensions of isolated mitochondria 
from rat renal cortex from control and NPX rats using a fluorometric method. Results are 
nmol/mg protein and are means ± SEM of measurements from three rats from each group. 
 
 
Parameter  Control NPX 
GSH 1.67 ± 0.08 1.97 ± 0.05* 
GSSG 0.90 ± 0.04 1.05 ± 0.02* 
 
* Significantly different (P<0.05) from the corresponding value in control rats. 
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Figure 4-1. Effect of compensatory renal growth on protein expression of renal 
mitochondrial GSH transporters.  
Mitochondrial samples were isolated from rat kidney cortex of control (CON) and 
uninephrectomized (NPX) rats and subjected to immunoblotting with anti-DIC, -OGC and -
VDAC. The VDAC protein served as a mitochondrial loading control. Note that the OGC protein 
was detected as both monomers (Mr = 32.5 kDa) and a dimer (Mr = 65 kDa). Blots were scanned 
and quantified by densitometry using GelEval 1.22 software. Data represent means ± SEM of 
measurements from renal mitochondrial samples from three CON and three NPX rats. No 
significant differences were detected between corresponding CON and NPX samples. 
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Table 4-2. Real-time quantitative PCR analysis of DIC and OGC mRNA expression in 
renal cortex of control and NPX rats. 
Primers were designed with the aid of Oligo 6.76 and the cDNA sequences published in 
GenBank
TM
. Primer and labeled probe sets were from Applied Biosystems. An optimum cDNA 
concentration of 30–300 ng DNA/well was determined for each gene. All CT values are based on 
the measurements of total RNA samples from kidney cortex of both control and NPX rats and 
are means ± SEM. GAPDH CT values were used for correction: For DIC and OGC samples, 
GAPDH CT values = 30.3 ± 0.2 for control rats and 30.4 ± 0.3 for NPX rats. Relative gene 
expression values were calculated by the formula: 2
-∆CT (NPX)
 / 2
-∆CT (Control), ∆CT value is the 
difference between the CT value for the gene of interest and that of GAPDH.     
 
Gene  Control 
CT mean ± SE 
NPX 
CT mean ± SE 
Relative Expression 
(NPX / Control) 
DIC (Slc22a10) 32.9 ± 0.2 33.4 ± 0.4 0.78 
OGC (Slc22a11) 33.6 ± 0.3 33.9 ± 0.1 0.89 
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Figure 4-2. Effect of compensatory renal growth on protein expression of renal 
mitochondrial Sod2 and Trx2.  
Mitochondrial samples were isolated from rat kidney cortex of control (CON) and 
uninephrectomized (NPX) rats and subjected to immunoblotting with anti-Sod2, anti-Trx2, and 
anti-prohibitin. The prohibitin protein served as a mitochondrial loading control. Blots were 
scanned and quantified by densitometry using GelEval 1.22 software. Data represent means ± 
SEM of measurements from renal mitochondrial samples from three CON and three NPX rats. 
No significant differences were detected between corresponding CON and NPX samples. 
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Discussion 
Although most of the GSH detected when one measures total cellular content resides in the 
cytoplasm, changes in the status of GSH in the mitochondrial pool would also be expected to 
occur. Such changes in mitochondrial GSH content have important impacts on mitochondrial 
function, cellular energetics, and ultimately cell viability (Lash et al., 1998). The present study 
demonstrated a significantly higher level of GSH specifically in renal mitochondria from NPX 
rats as compared to those from control rats. Because GSH synthesis in the renal PT cell only 
occurs in the cytoplasm (McKernan et al., 1991), transport of GSH across the mitochondrial 
inner membrane would appear to be the sole source of GSH for the mitochondrial matrix. In the 
renal cortex and PT cell, the DIC and OGC are the two carriers we identified as being 
responsible for this transport process (Chen and Lash, 1998; Chen et al., 2000). The functional 
importance of this renal mitochondrial GSH pool has been demonstrated in studies in which 
genetic manipulation of DIC or OGC expression markedly altered redox status and susceptibility 
to oxidants and other nephrotoxicants (Lash et al., 2002a 2002b; Xu et al., 2006). 
 
Besides showing an increase in mitochondrial GSH content, we previously found markedly 
increased rates of GSH uptake into renal mitochondria (Lash et al., 2001a). While this suggested 
to us that expression of the DIC and/or the OGC might be up-regulated in compensatory renal 
hypertrophy, measurements of both mRNA and protein expression for the two mitochondrial 
carriers showed no differences between control and NPX rats. To understand, then, what is 
responsible for the increased content of GSH in renal mitochondria from NPX rats, one has to 
consider the functions of the DIC and OGC in dicarboxylate transport and the observations that 
activities of several mitochondrial dehydrogenases and succinate-dependent respiration were 
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significantly higher in renal mitochondria from NPX rats. The increased mitochondrial uptake of 
GSH in compensatory renal hypertrophy, therefore, is likely due to kinetic or mass action effects 
resulting from the hypermetabolic state. In other words, the higher supply of dicarboxylate 
substrate for the two carriers drives the uptake of GSH into the mitochondria. 
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Impact of compensatory hypertrophy on functional characteristics of renal mitochondria 
 
Enzyme results  
Activities of several enzymes that are indicative of cellular energetics and redox status were 
measured in preparations of mitochondria and cytoplasm from renal cortex of control and NPX 
rats (Table 4-3). With the exception of small decreases in mitochondrial GPX and cytoplasmic 
GST in kidneys of NPX rats, there were no significant differences in activities of GSH-
dependent detoxification enzymes between control and NPX rat kidneys. In contrast, activities of 
malic dehydrogenase, glutamate dehydrogenase and succinate: cytochrome c oxidoreductase 
were significantly higher in renal mitochondria from NPX rats as compared to those from control 
rats. These increases in key enzymes of mitochondrial intermediary metabolism without 
corresponding changes in mitochondrial GSH-dependent enzymes are consistent with there being 
changes in mitochondrial redox status in kidneys of NPX rats. 
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Table 4-3. Effect of compensatory renal hypertrophy on GSH-dependent and 
mitochondrial enzymes. 
Enzyme activities were measured in cytoplasm or mitochondria isolated from kidney(s) of 
uninephrectomized (NPX) rats at 10 days post-surgery and age-matched control rats. Results are 
expressed as mU/mg protein and are means ± SEM of measurements from six rats from each 
group. 
Enzyme Control 
mU/mg protein 
NPX 
mU/mg protein 
GSSG Reductase        
Mitochondria          16.5 ± 1.8 19.9 ± 0.9 
Cytoplasm   21.1 ± 0.8 19.6 ± 0.8 
GSH peroxidase   
Mitochondria          12.6 ± 0.5 9.69 ± 0.06* 
Cytoplasm   11.7 ± 0.9 10.9 ± 0.8 
GSH S-transferase   
Mitochondria          4.91 ± 0.97 2.71 ± 0.31* 
Cytoplasm   34.1 ± 0.7 25.6 ± 0.2* 
Malic dehydrogenase   
Mitochondria          27.1 ± 1.7 38.3 ± 1.4* 
Glutamate dehydrogenase   
Mitochondria          57.7 ± 4.2 77.5 ± 6.1* 
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Succinate: cytochrome c oxidoreductase   
Mitochondria          28.7 ± 1.1 56.7 ± 4.2* 
      
 
*Significantly different (P < 0.05) from the corresponding value in control rats. 
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Respiration results 
Succinate-stimulated (complex II) state 3 respiration was also higher in renal mitochondria from 
NPX rats than in those from control rats (Table 4-4). Similarly, the RCR value, which gives an 
indication of how well oxygen consumption is coupled to ADP phosphorylation, was 
significantly elevated with succinate (complex II) as respiratory substrate in renal mitochondria 
from NPX rats relative to that in renal mitochondria from control rats. This significant 
acceleration of mitochondrial respiratory activity after compensatory renal cellular hypertrophy 
is consistent with the increased activities of mitochondrial dehydrogenases noted above and the 
general hypothesis that renal mitochondria from NPX rats are in a hypermetabolic state. 
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Table 4-4. Effects of compensatory renal hypertrophy on mitochondrial respiration. 
Mitochondrial succinate-dependent State 3 and State 4 respiration were measured in suspensions 
of isolated mitochondria from kidney(s) of control and NPX rats. Rates of oxygen consumption 
were determined in an Oxygraph with a Clark-type electrode using 3.3 mM succinate as 
respiratory substrate in the presence of 5 µM rotenone. Results are means ± SEM of 
measurements from six separate mitochondrial preparations from each group. 
RCR= respiratory control ratio = State 3 rate / State 4 rate. 
 
Parameter  Control NPX 
State 4 (nmol O2/min per mg protein) 18.6 ± 1.4 19.7 ± 1.0 
State 3 (nmol O2/min per mg protein) 27.0 ± 2.8 41.7 ± 1.5* 
RCR 1.88 ± 0.02 3.16 ± 0.10* 
 
 
*Significantly different (P<0.05) from the corresponding value in mitochondria from control 
rats. 
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Proteomics results 
To further explore mitochondrial energetics data (enzyme activities and respiration), a 
proteomics analysis of mitochondria from control and NPX rats was conducted to obtain an 
overview of mitochondrial protein levels. Using the SEQUEST and X!Tandem search engines, a 
total of 117 proteins were identified with ≥ 99% probability. Using the Mascot search engine, a 
total of 72 proteins were identified with ≥ 95% probability, of which 25 proteins were 
quantitated. For each protein, relative quantitation was calculated. As shown in Table 4-5, all the 
numbers in bold print signify a 1.5-fold or higher difference.  
 
In order to facilitate interpretation of mitochondrial proteomics data, we divided mitochondrial 
proteins into different categories and defined proteins belonging to the respective categories. The 
energy production category involves proteins that are involved in ATP synthesis and many 
metabolic pathways such as the tricarboxylic acid cycle, electron transport chain, amino acid, 
fatty acid, ketone body and drug metabolism. The apoptosis category is composed of proteins 
known to play a role in mitochondrial stress response. The data show an increase in expression 
of proteins that are involved in ATP synthesis, stress response, tricarboxylic acid (citric acid) 
cycle, respiratory electron transport chain and various metabolic pathways including amino acid, 
fatty acid and ketone body metabolism in the NPX group, further suggesting that a 
hypermetabolic state exists after uninephrectomy and compensatory renal growth. 
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Table 4-5. Mitochondrial Proteomics. 
All the numbers in bold print signify a 1.5 fold or higher difference.  
Relative quantitation: average signal intensity (NPX) / average signal intensity (Control) 
 
Accession  NPX/Con 
 ATP Synthesis, Transport and Metabolic Processes  
P10719 ATP synthase subunit beta 1.2 
Q98QB6 ATP synthase subunit beta 2 (ATP synthase F1 sector subunit beta 2)  1.5 
P15999 ATP synthase subunit alpha 1.5 
P05141 ADP/ATP translocase 2 (ADP,ATP carrier protein 2) 0.8 
 Stress Response Proteins  
Q64433 10 kDa heat shock protein (Hsp10)  1.4 
P63038 Heat shock protein 60 (HSP-60)  1.7 
 Tricarboxylic acid cycle (Citrate Cycle)  
P56574 Isocitrate dehydrogenase [NADP], (Oxalosuccinate decarboxylase) 1.6 
Q9ER34 Aconitate hydratase, (Aconitase)  2.5 
 Respiratory Electron Transport Chain  
Q52V09 Cytochrome c  1.4 
P13803 Electron transfer flavoprotein subunit alpha 1.0 
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Q66HF1  NADH-ubiquinone oxidoreductase 75 kDa subunit 1.9 
 Amino Acid and Fatty Acid Metabolic Pathways   
P50442 Glycine amidinotransferase, (Transamidinase) 1.9 
Q64565 Alanine-glyoxylate aminotransferase 2, (Beta-alanine-pyruvate 
aminotransferase) 
2.1 
Q02253 Methylmalonate-semialdehyde dehydrogenase  (Malonate-
semialdehyde dehydrogenase) 
1.3 
P08503 Medium-chain specific acyl-CoA dehydrogenase 2.6 
Q64428 Trifunctional enzyme subunit alpha, (3-hydroxyacyl-CoA 
dehydrogenase) 
0.7 
P26443 Glutamate dehydrogenase 1 1.9 
 Ketone Metabolism  
Q9D0K2 Succinyl-CoA:3-ketoacid-coenzyme A transferase 1, (3-oxoacid 
CoA-transferase 1)  
1.5 
 Drug Metabolism   
Q64573 Kidney microsomal carboxylesterase (Liver carboxylesterase 3)  1.5 
 Anion Transport (Transmembrane Transport)  
Q9Z2L0 Voltage-dependent anion-selective channel protein 1 (VDAC-1)  1.1 
 Amino acid Transport  
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Q64319 Neutral and basic amino acid transport protein rBAT (B(0,+)-type 
amino acid transport protein)  
1.0 
 Oxidoreductase Activity  
Q6AYT0 Quinone oxidoreductase (Zeta-crystallin)  1.2 
Q07523 Hydroxyacid oxidase 2  1.0 
Q68FT3 Probable oxidoreductase C10orf33 homolog  1.9 
Q9DBF1 Aldehyde dehydrogenase family 7 member A1 (Antiquitin-1)  0.9 
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Discussion 
The basic concept of the hypermetabolic state that is suggested to exist in compensatory renal 
hypertrophy is that the remnant renal tissue must work harder to try and make up for the lost 
function. The principal means to accomplish this is through increased generation of ATP by the 
mitochondria, which is tightly regulated in the kidneys according to the need for metabolic 
energy (Soltoff, 1986). In the present study, evidence for increased rates of mitochondrial 
metabolism were the significant increases in activities of malic, glutamate, and succinate 
dehydrogenases and State 3 rates of succinate-dependent respiration. We also observed 
significantly higher protein expression of the (Na
+
+K
+
)-ATPase in kidneys from NPX rats, 
which agrees with our previous observation of higher enzymatic activity in renal PT cells from 
NPX rats (Lash et al., 2001b). Because this protein is one of the primary consumers of ATP in 
the renal PT cell (Soltoff, 1986), its higher expression and activity in kidneys from NPX rats as 
compared to those from control rats provide further support for the conclusion that compensatory 
renal hypertrophy generates a hypermetabolic state in the remnant renal cell due to increased 
energy demands. 
 
In this study, we applied proteomics for relative quantification of mitochondrial proteins and 
analyzed the main pathways of mitochondrial activity for energy metabolism and stress response. 
Consistent with mitochondrial enzyme and respiration data, mitochondrial proteomics data also 
suggest the existence of a hypermetabolic state and stress in mitochondria from hypertrophied 
kidney. As mitochondrial proteins are central to various metabolic activities, disturbance of 
mitochondrial proteins is also often associated with a variety of diseases or various pathological 
states such as respiratory chain defects, fatty acid oxidation deficiencies and neurodegenerative 
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disease (Chan, 2006; Janssen et al., 2004; Gregersen et al, 2004; Kwong et al., 2006). This 
assessment of mitochondrial proteins provides specific, mechanistic information about molecular 
changes that influence cellular metabolism in mitochondria from both hypertrophied and normal 
kidney. 
 
Overall, our enzyme, respiration and proteomics data suggested a hypermetabolic state in 
hypertrophied kidney. As mitochondria are the major organelles to produce superoxide anion in 
cells, increased mitochondrial respiration and mitochondrial function also suggests potential 
increase in reactive oxygen species (ROS) formation, which in turn possibly lead to a higher 
basal state of oxidant stress as compared to mitochondria from normal rat kidneys. In addition, 
the upregulation of mitochondrial proteins that are involved in metabolic pathways and apoptosis 
might be a way for cells to cope with potential basal oxidative stress during compensatory renal 
hypertrophy. 
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Assessment of basal and toxicant-induced oxidative stress in renal mitochondria 
 
Results 
The hypermetabolic state of renal mitochondria from NPX rats, and the evidence of renal 
dysfunction, suggest that a higher state of oxidative stress exists that may contribute to higher 
susceptibility to chemically induced injury. To compare basal and toxicant induced oxidative 
stress between renal mitochondria from control and NPX rats, we analyzed lipid peroxidation by 
using two assays (one assay based on MDA formation and one based on degradation of cis-
parinaric acid) and measured aconitase activity as a marker for mitochondrial oxidative stress. 
We also examined two types of protein adducts as oxidative stress markers, 3-NT (3-
nitrotyrosine) and HNE (4-hydroxy-2-nonenal). 
 
The results of the MDA assay show that there is no significant difference in renal mitochondrial 
lipid peroxidation between control and NPX rats under either basal conditions or when 
mitochondria are challenged by exposure to tBH (Figure 4-3A). The naturally occurring 
polyunsaturated fatty acid cis-parinaric acid is used in eukaryotic cells as a very sensitive marker 
for the initial stages of lipid peroxidation (Tribble et al., 1994). When double bonds of cis-
parinaric acid are broken in lipid peroxidation reactions, decay in fluorescence is used to 
indirectly monitor the degree of membrane lipid peroxidation. Under anaerobic conditions (N2 + 
Fe
2+
), there was no significant difference in either basal or tBH-induced mitochondrial lipid 
peroxidation between control and NPX rats (Figure 4-3B). 
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Because mitochondrial aconitase activity is a sensitive indicator of redox homeostasis and its 
activity is uniquely sensitive to various physiological and pathological conditions (James et al., 
2002), it is frequently viewed as a marker of oxidative stress in biological systems. The 
underlying mechanism is believed to be the facile inactivation of its iron–sulfur prosthetic group 
by toxicants such as peroxides (Han et al., 2003; James et al., 2002; Gardner et al., 1994). As 
shown in Figure 4-3C, renal aconitase activity was significantly lower in mitochondria from 
NPX rats relative to control rats even without any exogenous toxicant, suggesting that renal 
compensatory hypertrophy does cause an increase in underlying mitochondrial oxidative stress. 
The progressive oxidative stress in animals with renal insufficiency can lead to oxidation of 
proteins, carbohydrates, nucleic acids, lipids and accumulation of harmful byproducts in various 
tissues (Himmelfarb et al., 2002; Vaziri, 2004). As a further assessment of mitochondrial redox 
status, we analyzed protein adducts of two oxidative stress markers, 3-NT and HNE, by Western 
blot analysis in renal mitochondria. No differences were observed in blots for 3-NT modified 
proteins (data not shown). However, assessment of HNE-adducted proteins showed significantly 
higher staining in renal mitochondria from NPX rats, with the most prominent staining at 45 kDa 
and 52 kDa (Figure 4-3D). 
 
To analyze the effect of toxicant (tBH) on mitochondrial protein levels, we performed proteomic 
analyses on mitochondrial samples from control and NPX groups. Using the Mascot search 
engine, a total of 72 proteins were identified with ≥ 95% probability, of which 25 proteins were 
quantitated. For each protein, relative quantitation was calculated. As shown in Table 4-6, all the 
numbers in bold print signify a 1.5-fold or higher difference and a 0.5-fold or lower difference.  
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The comparison of NPX-tBH/Control-tBH protein expression cannot clearly suggest if changes 
are due to the effects of nephrectomy or toxicant-treatment. To further explore these data, we 
also analyzed the protein fold change using NPX-tBH/NPX and Control-tBH/Control 
comparisons. The data show that tBH treatment caused a significant decrease in expression of 
proteins in mitochondria from both control (Control-tBH/Control) and NPX (NPX-tBH/NPX) 
groups. This lower protein expression may be a result of cellular toxicity due to too high a 
concentration of or exposure time to tBH. In addition, tBH treatment had similar effects on 
mitochondrial proteins from both control and NPX groups that are involved in the citric acid 
cycle, electron transport chain, amino acid, fatty acid, ketone and drug metabolism. 
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Figure 4-3. Assessment of effects of compensatory renal growth on basal and toxicant-
induced oxidative stress in renal mitochondria. 
A. Basal and tBH-induced lipid peroxidation in renal mitochondria from CON and NPX rats was 
measured using malondialdehyde (MDA) formation, as determined with 1-methyl-2-
phenylindole. Renal mitochondrial samples from CON and NPX rats were incubated with buffer 
or 500 µM tBH for 1h. Results are means ± SEM of three separate samples from each group. 
*Significantly different (P < 0.05) from the corresponding untreated samples. 
B. Basal and tert-butyl hydroperoxide (tBH)-induced lipid peroxidation in renal mitochondria 
from control (CON) and uninephrectomized (NPX) rats was measured using fluorescent cis-
parinaric acid. Renal mitochondrial samples were incubated with 6.4 mM cis-parinaric acid + 5 
mM hemin and treated with either 200 µM or 500 µM tBH. Results are means ± SEM of three 
separate samples from each group. *Significantly different (P < 0.05) from the corresponding 
untreated samples. 
C. Mitochondrial aconitase activity in renal mitochondria from CON and NPX rats was 
measured as NADPH formation at A340. Results are means ± SEM of three separate samples 
from each group. *Significantly different (P < 0.05) from the value in mitochondria from CON 
rats. 
D. Adducts of 4-hydroxy-2-nonenal (HNE) with mitochondrial proteins were determined by 
Western blot analysis. VDAC protein was used as a mitochondrial loading control. Blots were 
quantified by densitometry using GelEval 1.22 software. Data are presented as means ± SEM of 
three separate samples from each group. *Significantly different (P < 0.05) compared to 
corresponding sample from CON rats. 
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Table 4-6. Effect of toxicant (tBH) on mitochondrial protein expression during compensatory renal hypertrophy. 
All the numbers in bold print signify a 1.5-fold or higher difference and a 0.5-fold or lower difference.  
Relative quantitation:  average signal intensity (NPX-tBH) / average signal intensity (NPX) 
    average signal intensity (Control-tBH) / average signal intensity (Control) 
 average signal intensity (NPX-tBH) / average signal intensity (Control-tBH) 
    
Accession  NPX-tBH/ 
NPX 
Control-tBH/ 
Control 
 
NPX-tBH/ 
Control-tBH 
 ATP Synthesis, Transport and Metabolic 
Processes 
   
P10719  ATP synthase subunit beta 
0.9 0.6 1.5  
Q98QB6 ATP synthase subunit beta 2 (ATP synthase F1 
sector subunit beta 2)  
1.2 0.5 
 
3.2 
 
8
8
 
 
 
 
 
P15999 ATP synthase subunit alpha 
0.8 0.8 1.3 
P05141 ADP/ATP translocase 2 (ADP,ATP carrier 
protein 2) 
0.7 0.4 1.4 
 Stress Response Proteins    
Q64433 10 kDa heat shock protein (Hsp10)  
0.7 0.4 2.4 
P63038 Heat shock protein 60 (HSP-60)  
0.9 0.5 1.6 
 Tricarboxylic acid cycle (Citrate Cycle)    
P56574 Isocitrate dehydrogenase [NADP], 
(Oxalosuccinate decarboxylase) 
0.7 0.6 
 
1.2 
 
Q9ER34 Aconitate hydratase, (Aconitase)  
0.6 0.7 1.1 
 Respiratory Electron Transport Chain    
Q52V09 Cytochrome c  
0.5 0.3 2.3 
Q66HF1  NADH-ubiquinone oxidoreductase 75 kDa 
subunit 
0.2 0.1 0.4 
8
9
 
 
 
 
 
 Amino Acid and Fatty Acid Metabolic 
Pathways  
   
P50442 Glycine amidinotransferase, (Transamidinase) 
1.1 1.2 1.4 
Q64565 Alanine-glyoxylate aminotransferase 2, (Beta-
alanine-pyruvate aminotransferase) 
0.5 
 
0.6 
 
1.1 
 
Q02253 Methylmalonate-semialdehyde dehydrogenase  
(Malonate-semialdehyde dehydrogenase) 
0.7 
 
0.5 
 
1.8 
 
P08503 Medium-chain specific acyl-CoA 
dehydrogenase 
0.7 1.5 1.2 
Q64428 Trifunctional enzyme subunit alpha, (3-
hydroxyacyl-CoA dehydrogenase) 
0.5 
 
0.5 
 
1.0 
 
P26443 Glutamate dehydrogenase 1 
0.5 0.6 1.4 
P00507 Aspartate aminotransferase, mitochondrial 
precursor  (Transaminase A) 
3.6 4.8 
 
0.6 
 
9
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 Ketone Metabolism    
Q9D0K2 Succinyl-CoA:3-ketoacid-coenzyme A 
transferase 1, (3-oxoacid CoA-transferase 1)  
0.5 
 
0.6 
 
0.9 
 
 Drug Metabolism     
Q64573 Kidney microsomal carboxylesterase (Liver 
carboxylesterase 3)  
0.3 0.4 
 
1.5 
 
 Anion Transport (Transmembrane 
Transport) 
   
Q9Z2L0 Voltage-dependent anion-selective channel 
protein 1 (VDAC-1)  
1.2 0.6 
 
1.9 
 
 Amino acid Transport    
Q64319 Neutral and basic amino acid transport protein 
rBAT (B(0,+)-type amino acid transport 
protein)  
0.6 
 
0.5 
 
1.2 
 
9
1
 
 
 
 
 
 Oxidoreductase Activity    
Q6AYT0 Quinone oxidoreductase (Zeta-crystallin)  
0.8 0.9 1.1 
Q07523 Hydroxyacid oxidase 2  
0.6 0.5 1.3 
Q68FT3 Probable oxidoreductase C10orf33 homolog  
0.3 1.0 0.7 
Q9DBF1 Aldehyde dehydrogenase family 7 member A1 
(Antiquitin-1)  
1.7 0.6 
 
4.6 
 
 
9
2
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Discussion 
Inasmuch as the mitochondria are the principal intracellular sites of oxygen consumption and 
increased rates of electron transport are believed to be associated with increased release of 
reactive oxygen species, we hypothesized that the consequence of these changes in 
mitochondrial function is an enhancement of basal oxidant stress (Lash et al., 2001a). The 
current studies pursued this further by assessing both basal and toxicant-stimulated lipid 
peroxidation using two well-established assays, formation of MDA and degradation of cis-
parinaric acid. We also measured activity of mitochondrial aconitase, which, as noted above, is 
considered a highly sensitive indicator of oxidative stress due to the facile oxidation of its Fe-S 
cluster leading to inactivation (Han et al., 2003; James et al., 2002; Gardner et al., 1994). 
 
Neither assessment of lipid peroxidation showed a significant difference between control and 
NPX kidneys, either in the absence or presence of toxicant. Expression of two important redox 
proteins in renal mitochondria, SOD2 and Trx2, were also unchanged after compensatory renal 
hypertrophy. An important consideration in evaluating such data, however, is the manner by 
which the measurements are normalized. In the present work, enzyme activities and levels of 
metabolites were normalized to total protein content, which was the only normalization 
parameter available and is the one that is most commonly used. Part of the compensatory 
hypertrophy response, however, is an increase in protein per cell (Meyer et al., 1996; Fine, 1986; 
Shirley and Walter, 1991; Wolf and Neilson, 1991). We previously illustrated the impact of this 
by normalizing activities in renal PT cell primary cultures derived from either control or NPX 
rats to both protein and DNA content (Lash et al., 2001b). Whereas the amount of total protein 
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per cell increases as a consequence of compensatory renal hypertrophy, the amount of DNA per 
cell does not change owing to the absence of a significant hyperplasia after a reduction in renal 
mass. Thus, lack of a difference between samples from control and NPX rats when normalized to 
protein equates to an increase, although one that is proportional to protein. 
 
In contrast to the lipid peroxidation data, the mitochondrial aconitase activity data showed 
significant redox imbalance, suggesting an increase in mitochondrial oxidative stress in NPX 
kidney. To further support the conclusion that there is a degree of redox imbalance in renal 
mitochondria of NPX rats, we observed a significant increase in the amount of HNE-modified 
protein. The increase in Western blot density was 1.7-fold and was predominantly detected in 
two protein bands of molecular weight 52 kDa and 45 kDa. Although the identity of these 
modified proteins is currently unknown, their detection and the extent of the difference between 
renal mitochondria from control and NPX rats, suggest they may be important in determining the 
compensatory hypertrophy phenotype. Potential nitration of mitochondrial proteins was also 
assessed, but no difference between renal mitochondria from control and NPX rats was found, 
suggesting that increases in reactive nitrogen species were not a component of the compensatory 
hypertrophy phenotype. 
 
The relative quantitation of proteins from mitochondrial pathways enabled the detection of 
toxicant-induced changes in mitochondria from hypertrophied kidney, suggesting alterations in 
susceptibility to mitochondrial toxicants. Overall, the proteomic analysis identified a number of 
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toxicant-induced changes during compensatory renal hypertrophy that could be involved in 
mediating mitochondrial toxicant-induced oxidative stress. Further exploration of these changes 
may provide insight into whether or not mitochondrial toxicant-induced stress response in 
hypertrophied kidney is due to cell death or any other mechanism. From our data, it is not clear if 
the similar effect of the toxicant, tBH, on mitochondrial proteins from both control and NPX 
groups is due to use of too high a concentration of tBH or too long an exposure. It would be 
interesting to treat the mitochondria with multiple concentrations of toxicants in multiple 
mitochondrial samples from control and NPX groups. 
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Effect of compensatory renal hypertrophy on mitochondrial size, number and membrane 
potential 
 
Results 
Effect of compensatory renal hypertrophy on mitochondrial size and number in renal PT 
cells 
Based on contradictory data from previous studies (Cuppage et al., 1973; Hwang et al., 1990), 
our goal was to study basic properties of renal mitochondria after compensatory renal 
hypertrophy due to uninephrectomy. To label mitochondria, PT cells were incubated with 
MitoTracker
TM
 probes, which passively pass across plasma membranes and accumulate in 
metabolically active mitochondria. Our data showed a significant increase in mitochondrial 
staining with MitoTracker
TM
 dye in NPX rats, suggesting a possibility of either an increase in 
mitochondrial number (proliferation) or size (hypertrophy). To further explore these data, 
mitochondrial DNA and mitochondrial protein were measured. As shown in Figure 4-5 and 
Figure 4-6, the data indicate no significant difference in mitochondrial DNA but significant 
increases in mitochondrial protein contents in the NPX group, suggesting renal mitochondrial 
hypertrophy in the NPX group. 
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Renal PT cells from NPX rats have higher basal mitochondrial membrane potential than 
those from control rats 
To analyze mitochondrial membrane potential, PT cells were incubated with JC-1 (Figure 4-4). 
JC-1 is a cationic dye that exhibits membrane potential-dependent accumulation in mitochondria, 
indicated by shifting its fluorescence emission from green (~525 nm) to red (~590 nm). Polarized 
mitochondria are indicated by punctate red staining. The graphs represent average quantitation of 
three images and show a marked increase in JC-1 red punctate staining and no significant 
difference in JC-1 green staining. Overall, these data demonstrate an increase in JC-1 red 
punctate staining in kidneys of NPX rats, which is higher than the increase in MitoTracker
TM
 
staining, suggesting a hyperpolarized state in the kidneys of NPX rats. 
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Figure 4-4. MitoTracker
TM
 staining. 
PT cells were grown on 35 mm dishes for 4 days and incubated with MitoTracker
TM
 (50 nM) for 
30 min. MitoTracker
TM
 staining in PT cells from Control and NPX rats was measured using a 
Zeiss LSM 510 confocal microscope. 
A) Images of MitoTracker
TM
 staining were measured by confocal microscopy at 554 nm 
excitation and 576 nm emission. Magnification = 630x. 
B) The graph represents average quantitation of three images. The integrated intensity of the 
entire image was done using Metamorph 7.1.7.0 Offline. *Significantly different (P < 0.05) from 
control cells. 
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A. 
B. 
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Figure 4-5. Mitochondrial DNA. 
Mitochondrial DNA was measured by DNA fluorescence assay. DAPI fluorescence was 
measured at 360 nm excitation and 450 nm emission. Results are means ± SEM of three separate 
samples from each group. 
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Figure 4-6. Mitochondrial protein. 
Mitochondrial protein contents were measured by the BCA protein assay. *Significantly 
different (P < 0.05). Data are presented as means ± SEM of three separate samples from each 
group. 
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Figure 4-7. Measurement of mitochondrial membrane potential in PT cells from control 
and NPX rats. 
PT cells were incubated with JC-1 (5 µg/ml) for 30 min. JC-1 fluorescence was measured by 
confocal microscopy using an overlay of red (488 nm excitation, 590 nm emission) and green 
(488 nm excitation, 525 nm emission) on a Zeiss LSM 510 confocal microscope. 
A) JC-1 aggregate is indicated by red punctate staining (left panel). JC-1 monomer is indicated 
by green staining (middle panel). The overlay of both images is indicated by yellow color, which 
indicates co-localization of red and green (right panel). Magnification = 630x 
B) The graphs represent average quantitation of three images. The integrated intensity of the 
entire image was measured by using Metamorph 7.1.7.0 Offline. *Significantly different (P < 
0.05) from control cells. 
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Discussion 
In contrast to previous studies that suggested the existence of both renal mitochondrial 
proliferation and hypertrophy (Johnson and Amendola, 1969; Cuppage et al., 1973), Hwang‟s 
group (Hwang et al., 1990) concluded only mitochondrial hypertrophy of a fixed number of 
mitochondria in compensatory renal hypertrophy of renal PT cells. On the basis of these previous 
studies, which have suggested renal mitochondrial proliferation and hypertrophy, we analyzed 
properties of renal mitochondria after compensatory renal hypertrophy due to uninephrectomy. 
In the present study, we demonstrated the occurrence of renal mitochondrial hypertrophy 
following reduction in renal mass that was presumably to satisfy the greater need for energy 
metabolism (Benipal and Lash, 2011). This is consistent with data from the studies of Hwang 
and colleagues (Hwang et al., 1990). 
 
The elevation in basal mitochondrial membrane potential suggested the existence of a 
hyperpolarized state, which is consistent with our previous data of higher rates of state 3 
respiration in isolated renal mitochondria from NPX rats (Benipal and Lash, 2011). These data 
suggest that increased rates of electron flow and hyperpolarization by increased mitochondrial 
respiration further lead to increased reactive oxygen species formation, which potentially causes 
a significant degree of redox imbalance and basal oxidative stress in renal mitochondria, as 
suggested by our recent studies (Benipal and Lash, 2011), and increased susceptibility of PT 
cells from NPX rats to nephrotoxicants (Lash et al., 2006). 
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CHAPTER V.  MODULATION OF MITOCHONDRIAL REDOX STATUS IN PT 
CELLS TO REDUCE THE RISK OF SUSCEPTIBILTY TO NEPHROTOXICANTS. 
 
Influence of overexpression of the DIC on susceptibility to chemically induced toxicity by 
mitochondrial toxicants 
 
Results 
The overexpression of the DIC was confirmed by analyzing gene expression. As shown in Table 
5-1, overexpression of DIC plasmids leads to a 7,806-fold increase in DIC gene expression. 
Acute cytotoxicity was assessed by measuring lactate dehydrogenase (LDH) release in renal PT 
cells from NPX rats. After transfection with the DIC plasmid, the PT cells were treated with 
either AA (1 µM, 10 µM), tBH (100 µM, 200 µM) or MVK (100 µM, 200 µM) without or with 
an overnight supplementation with 5 mM GSH. With endogenous GSH, overexpression of DIC 
did not cause any significant change in LDH release induced by AA (Figure 5-1A). However, 
after supplementation of PT cells with GSH, overexpression of DIC caused protection against the 
mitochondrial specific toxicant AA (Figure 5-1B). Furthermore, overexpression of DIC did not 
cause any protection against tBH or MVK with endogenous or supplemented GSH in PT cells 
from NPX rats (Figure 5-1A and Figure 5-1B). 
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Table 5-1. Analysis of DIC gene overexpression by RT-PCR in renal proximal tubular cells 
from NPX rats. 
Primers for the DIC were designed with the aid of Oligo 6.76 and the cDNA sequences 
published in GenBank 
TM
. An optimum cDNA concentration of 30–300 ng DNA/well was 
determined for each gene. All CT values are based on triplicate measurements from total RNA 
from 3 renal PT cell preparations from NPX rats and are means ± SEM. GAPDH CT values were 
used for correction: For control and DIC-transfected samples, GAPDH CT values = 27.8 ± 0.2 
for control and 31.7 ± 0.5 for DIC-transfected. Relative gene expression values were calculated 
by the formula: 2
-∆CT (DIC-transfected)
 / 2
-∆CT (Control), ∆CT value is the difference between the CT value 
for the gene of interest and that of GAPDH. 
 
 
Control 
CT mean ± SE 
DIC-transfected 
CT mean ± SE 
Relative Expression 
(DIC-transfected / Control) 
30.3 ± 0.1 21.3 ± 0.2 7,806 
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Figure 5-1. Effect of overexpression of the DIC on sensitivity to chemical-induced toxicity. 
A. Experiments were performed on day 6 of cell culture (72 h post-DIC transfection). 
Suspensions of PT cells isolated from NPX rats were treated with the indicated concentrations of 
AA, MVK or tBH for 4 h. After 4 h, aliquots were removed and LDH activity was measured. 
Values represent means ± SEM. Data shown here are the average of three experiments.  
B. Experiments were performed on day 6 of cell culture (72 h post-DIC transfection). 
Suspensions of PT cells isolated from NPX rats were incubated with 5 mM GSH overnight prior 
to treatment with the indicated concentrations of AA, MVK or tBH for 4 h. After 4 h, aliquots 
were removed and LDH activity was measured. Values represent means ± SEM. Data shown 
here are the average of three experiments. *Significantly different (P < 0.05). 
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Figure 5-1B. 
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Influence of overexpression of the OGC on susceptibility to chemically induced toxicity by 
mitochondrial toxicants 
 
Results 
Overexpression of the OGC was confirmed by analyzing gene expression. As shown in Table 5-
2, overexpression of OGC plasmids lead to a 5,007-fold increase in OGC gene expression. Acute 
cytotoxicity was assessed by measuring LDH release in PT cells from NPX rats. After 
transfection with the OGC plasmid, the PT cells were treated with either AA (1 µM, 10 µM), 
tBH (100 µM, 200 µM) or MVK (100 µM, 200 µM) without or with an overnight 
supplementation with 5 mM GSH. With endogenous GSH, overexpression of OGC did not cause 
any significant change in LDH release induced by AA (Figure 5-2A). However, after 
supplementation of PT cells with GSH, overexpression of OGC caused protection against the 
mitochondrial specific toxicant AA (Figure 5-2B). Furthermore, overexpression of OGC did not 
cause any protection against tBH or MVK with either endogenous or supplemented GSH 
(Figure 5-2A and Figure 5-2B) in PT cells from NPX rats. 
 
Overall, these results suggest higher GSH transport activity by overexpression of DIC and OGC 
in renal PT cells of hypertrophied kidney markedly protected against toxicity and oxidative stress 
induced by the mitochondrial selective toxicant AA, indicating the significance of mitochondrial 
GSH transport in determining susceptibility to cytotoxic chemicals. 
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Table 5-2. Analysis of OGC gene overexpression by RT-PCR in renal proximal tubule cells 
of NPX rats. 
Primers for the OGC were designed with the aid of Oligo 6.76 and the cDNA sequences 
published in GenBank 
TM
. An optimum cDNA concentration of 30 to 300 ng DNA/well was 
determined for each gene. All CT values are based on triplicate measurements from total RNA 
from 3 renal PT cell preparations from NPX rats and are means ± SEM. GAPDH CT values were 
used for correction: For control and OGC-transfected samples, GAPDH CT values = 27.8 ± 0.1 
for control and 28.3 ± 0.2 for OGC-transfected. Relative gene expression values were calculated 
by the formula: 2
-∆CT (OGC-transfected)
 / 2
-∆CT (Control), ∆CT value is the difference between the CT 
value for the gene of interest and that of GAPDH. 
 
 
 
 
 
 
 
 
 
 
 
Control 
CT mean ± SE 
OGC-transfected 
CT mean ± SE 
Relative Expression 
(OGC-transfected / Control) 
31.8 ± 0.3 20.0 ± 0.5 5,007 
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Figure 5-2. Effect of overexpression of the OGC on sensitivity to chemical-induced toxicity. 
A. Experiments were performed on day 6 of cell culture (72 h post-OGC transfection). 
Suspensions of PT cells isolated from NPX rats were treated with the indicated concentrations of 
AA, MVK or tBH for 4 h. After 4 h, aliquots were removed and LDH activity was measured. 
Values represent means ± SEM. Data shown here are the average of three experiments.  
B. Experiments were performed on day 6 of cell culture (72 h post-OGC transfection). 
Suspensions of PT cells isolated from NPX rats were incubated with 5mM GSH overnight prior 
to treatment with the indicated concentrations of AA, MVK or tBH for 4 h. After 4 h, aliquots 
were removed and LDH activity was measured. Values represent means ± SEM. Data shown 
here are the average of three experiments. *Significantly different (P < 0.05). 
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Discussion 
Our previous reports showed a significant degree of redox imbalance and basal oxidative stress 
in renal mitochondria (Benipal and Lash, 2011) and an increased susceptibility of PT cells from 
NPX rats to nephrotoxicants (Lash et al., 2006). Furthermore, our lab also showed in NRK-52E 
cells that overexpression of mitochondrial GSH transporters protected against nephrotoxicants 
(Lash et al., 2002b; Xu et al., 2006). Taken together, these observations suggested that a 
threshold level of mitochondrial GSH is needed to counteract oxidative stress and susceptibility 
to toxicants in PT cells. Thus, we hypothesized that further increases in mitochondrial GSH 
levels in PT cells by overexpression of DIC and/or OGC will improve mitochondrial energetics 
and redox status and lower susceptibility to mitochondrial toxicants. 
 
In this study, our approach was to increase GSH content in a subcellular organelle, mitochondria, 
by altering expression of the DIC and OGC to effect desired changes in mitochondrial GSH 
status. To investigate the toxicological consequences of altering mitochondrial GSH transport, 
we incubated renal PT cells from NPX rats with three mechanistically distinct mitochondrial 
toxicants, AA, tBH, and MVK. All three toxicants are unique in their mechanisms as shown in 
Figure 5-3. AA is a specific mitochondrial inhibitor that decreases mitochondrial electron 
transport chain activity and mitochondrial membrane potential leading to increases in reactive 
oxygen species. tBH is an oxidant that causes lipid peroxidation and GSH oxidation whereas 
MVK is an alkylating agent that causes GSH depletion by formation of GSH adducts. 
 
Interestingly, assessment of cytotoxicity by LDH release demonstrated that overexpression of 
either of the mitochondrial GSH carriers, the DIC and OGC, only protected against AA. This 
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extensive protection against AA by overexpression of mitochondrial GSH transporters can be 
explained by a direct effect of AA on the mitochondrial electron transport chain. In other words, 
out of all three toxicants, AA specifically inhibits mitochondria and consequently, increased 
mitochondrial GSH by overexpression of GSH transporters decreases the oxidative stress 
induced by AA. Thus, consistent with our previous data in NRK-52E cells (Lash et al., 2002b; 
Xu et al., 2006), our present data also demonstrated that manipulation of mitochondria by 
overexpression of mitochondrial GSH carriers, DIC and OGC, reduced the risk of susceptibility 
to nephrotoxicants in hypertrophied kidney cells. 
 
Overall, our data represent a significant analysis of the influence of modulation of renal 
mitochondrial GSH transport on the influence of compensatory renal hypertrophy on 
susceptibility of renal PT cells to mitochondrial toxicants. Furthermore, it would be interesting to 
extend this study by analyzing the effect of overexpression of the mitochondrial GSH 
transporters, DIC and OGC, on oxidative stress, proliferation and cellular GSH status. The 
ultimate goal of this study is to improve renal redox status after reduction in kidney mass by 
increasing mitochondrial GSH. This is then intended to reduce the risk of susceptibility to 
nephrotoxicants as reported by our previous studies (Lash et al., 2006; Lash et al., 2002b; Xu et 
al., 2006). Besides compensatory renal hypertrophy after reduction in kidney mass, GSH 
dysregulation is also associated with a number of toxic and pathological states. For example, 
lower cellular GSH levels are associated with diabetes, neurodegeneration and cardiovascular 
diseases (Ballatori et al., 2009) and depletion or oxidation of mitochondrial GSH is associated 
with cirrhosis, diabetic nephropathy and alcoholic liver disease (Fernandez-Checa et al., 1993; 
Krahenbuhl et al., 1992; Santos et al., 2003; Mastrocola et al., 2005). Towards this end, our 
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approach of improving cellular and subcellular (mitochondrial) GSH status might be applicable 
to not only compensatory renal hypertrophy but also to diseases that are associated with GSH 
dysregulation. 
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Figure 5-3. Mitochondrial toxicants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B) tert-butyl hydroperoxide 
A) Antimycin A 
C) Methyl vinyl ketone 
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CHAPTER VI.  SUMMARY AND CONCLUSIONS 
The primary goal of this dissertation was to further characterize renal function and mitochondrial 
status during compensatory renal hypertrophy caused by uninephrectomy and to further expand 
on our previous studies of modulating renal mitochondrial redox status. We hypothesize that 
compensatory renal hypertrophy after uninephrectomy alters renal function and mitochondrial 
status and modulation of mitochondrial redox status alters susceptibility to nephrotoxicants in 
hypertrophied kidney cells. To study compensatory renal hypertrophy, we used the 
uninephrectomy rat model as this model has been reasonably well characterized as to the 
physiological and morphological changes that occur. 
 
The analysis of renal physiological parameters suggested that the compensatory response of the 
remaining kidney after uninephrectomy is associated with modest impairment of renal function 
as assessed by blood and urinary parameters. The previous observations suggested that 
compensatory renal hypertrophy is associated with a significant increase in GSH content by 
higher activity of -glutamylcysteine synthetase (GCS). To further explore another potential 
mechanism for the increase in the cytoplasmic pool of GSH, we analyzed the expression of 
several plasma membrane carrier proteins that are responsible for GSH transport into PT cells to 
determine whether or not there is increased transport of GSH across the BLM. Our results 
showed significantly higher protein expression of Oat1 and Oat3, which play a role in GSH 
uptake, and higher protein expression of the (Na
+
+K
+
)-stimulated ATPase, which provides the 
Na
+
 ion gradient for secondary active transporters that ultimately help mediate the uptake of 
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GSH. Overall, these results suggested that higher intracellular accumulation of GSH is due to 
higher activity of GCS and increased GSH transport across the BLM. 
 
After analyzing renal plasma membrane GSH transporters, the next goal was to see whether or 
not compensatory renal hypertrophy caused alterations in renal mitochondrial redox status, 
including GSH and the redox enzymes superoxide dismutase (Sod2) and thioredoxin2 (Trx2). 
The analysis of renal mitochondrial glutathione status showed modest but significant increases in 
both GSH and GSSG in renal mitochondria from NPX rats as compared to control rats. We next 
determined gene and protein expression of two inner mitochondrial carrier proteins, the DIC and 
OGC, which partially determine renal mitochondrial GSH status. In contrast to our expectations, 
neither gene nor protein expression of the DIC or OGC were increased and there were no 
changes in protein expression of the mitochondrial redox enzymes Sod2 and Trx2 after 
uninephrectomy. Hence, we concluded that the increase in mitochondrial GSH concentrations is 
due to mass action or changes in the kinetics of the mitochondrial GSH transporters, DIC and 
OGC, caused by a hypermetabolic state. 
 
To analyze the impact of compensatory renal hypertrophy on functional characteristics of renal 
mitochondria, we analyzed activities of mitochondrial enzymes that are indicative of cellular 
energetics and redox status. To further explore mitochondrial energetics, we also looked at 
mitochondrial respiration and proteomics. All the results provided evidence for a hypermetabolic 
state in the NPX group signified by increases in activities of energetics enzymes, state 3 rates of 
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respiration and expression of proteins that are involved in various metabolic pathways. Overall, 
these observations suggest that to accommodate the increased energy demand caused by 
compensatory renal hypertrophy, there are increased rates of mitochondrial electron transport 
chain leading to the hypermetabolic state that can also lead to mitochondrial dysfunction due to 
increased ROS formation. 
 
The evidence for renal dysfunction and a hypermetabolic state of renal mitochondria from NPX 
rats suggested that a higher state of mitochondrial oxidative stress exists that may also contribute 
to higher susceptibility to chemically induced renal injury. Hence, our next goal was to compare 
basal and toxicant-induced renal mitochondrial oxidative stress between control and NPX rats. 
We analyzed both basal and toxicant-stimulated lipid peroxidation and aconitase activity, which 
is a highly sensitive indicator of oxidative stress in biological systems. The assessment of basal 
and toxicant-induced lipid peroxidation data showed no significant difference between control 
and NPX kidneys. However, aconitase activity data suggested redox imbalance leading to 
increased mitochondrial oxidative stress, which is further supported by significant increases in 
the amount of HNE-adducted proteins in renal mitochondria from NPX rats. 
 
Based on previous observations that were contradictory and suggested both renal mitochondrial 
proliferation and hypertrophy on the one hand and only mitochondrial hypertrophy on the other 
hand, our goal was to further explore the effect of compensatory renal hypertrophy on 
mitochondrial size and number in renal PT cells. We showed that mitochondrial hypertrophy of 
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renal PT cells follows reduction in renal mass to satisfy the need for energy metabolism during 
compensatory renal hypertrophy. Furthermore, elevation in basal membrane potential as shown 
by JC-1 staining suggested a hyperpolarized state in mitochondria from the NPX group. This 
suggested that hyperpolarization caused by increased mitochondrial respiration further leads to 
basal mitochondrial oxidative stress and increased susceptibility of PT cells to nephrotoxicants in 
the NPX group. 
 
Finally, to test our hypothesis that increasing renal mitochondrial GSH reduces the risk of 
susceptibility to nephrotoxicants in hypertrophied kidney cells, we overexpressed two 
mitochondrial GSH carriers, the DIC and OGC, in PT cells from the NPX group. The basic idea 
was that overexpression of mitochondrial GSH transporters would decrease susceptibility to 
nephrotoxicants by increasing mitochondrial GSH levels caused by increased expression and 
transport activity of GSH transporters, the DIC and OGC. The assessment of cytotoxicity 
showed that after supplementation of PT cells with GSH, overexpression of mitochondrial GSH 
transporters protected against the mitochondrial specific toxicant antimycin A. These data 
supported our hypothesis that higher mitochondrial GSH transport activity by overexpression of 
the DIC and OGC in hypertrophied kidney cells markedly protected against toxicity, supporting 
the significance of mitochondrial GSH transport in determining susceptibility to toxicants. 
 
In summary, we showed that in hypertrophied kidney there are alterations in physiological 
parameters suggesting modest renal dysfunction, higher expression of renal organic anion 
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transporters suggesting higher transport of GSH and higher transport of xenobiotics leading to an 
increase in susceptibility to nephrotoxicants, and alterations in hypertrophied mitochondria 
suggesting redox imbalance and increased basal oxidative stress. As shown in Figure 6-1, we 
conclude that in hypertrophied mitochondria, a hypermetabolic state caused by increases in citric 
acid cycle and electron transport chain activities lead to a hyperpolarized state and superoxide 
production, which further causes mitochondrial oxidative stress. Furthermore, the increase in 
mitochondrial GSH concentrations is due to mass action or a kinetic effect on mitochondrial 
GSH transporters. In addition, our data also provide evidence that manipulation of mitochondrial 
GSH transport modulates response to nephrotoxicants, supporting the toxicological significance 
of the mitochondrial GSH transport process in compensatory renal hypertrophy. 
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Figure 6-1. Summary scheme. 
Abbreviations: DIC, dicarboxylate carrier; ROS, reactive oxygen species; O2
-
, superoxide anion; 
OGC, oxoglutarate carrier; 2-OG
2–
, 2-oxoglutarate; Pi
2-
, inorganic phosphate; TCA, tricarboxylic 
acid cycle.   
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CHAPTER VII. OVERALL SIGNIFICANCE AND FUTURE DIRECTIONS 
 
Reduction in renal mass and function afflicts millions of people worldwide as a consequence of 
several renal and non-renal diseases, infections, aging and surgery due to nephrectomy. 
Uninephrectomy, or surgical removal of one kidney, is performed for treatment in critical cases 
of renal diseases, injuries and for the purpose of kidney transplantation. Due to increasing 
incidence of reductions in kidney mass, high medical expenditures represent a significant 
challenge to public health care in the U.S. Although the remaining functional renal mass 
compensates for the loss of renal function, reduced kidney mass due to nephrectomy is a 
pathophysiologic process that is associated with alterations in renal hemodynamics, physiology 
and biochemistry. 
 
Numerous human clinical and experimental animal studies have provided evidence that 
reduction in renal mass leads to proteinuria, hypertension, hyperfiltration, glomerulosclerosis and 
toxicological implications such as increased nephrotoxicity from many drugs. In this study using 
a uninephrectomized rat model, we showed that compensatory renal hypertrophy due to 
reduction in renal mass is associated with modest renal dysfunction, alterations in renal 
mitochondrial glutathione and energetics status and mitochondrial oxidative stress. Furthermore, 
we also expanded our previous studies of modulating renal mitochondrial redox status and 
showed that an increase in renal mitochondrial GSH status reduces the risk of susceptibility to 
cytotoxic chemicals. Thus, we have taken several comprehensive and diversified approaches to 
study the role of mitochondrial energetics and redox status in the compensatory renal 
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hypertrophy response including in vivo, ex vivo (isolated renal mitochondria), and in vitro (in 
primary cultures of PT cells). 
 
Our particular focus on mitochondrial status is significant because alterations in mitochondrial 
function have been associated with numerous diverse pathologies. Changes in mitochondrial 
redox status likely underlie the regulation of mitochondrial and cellular energetics and cellular 
responses to many chemical exposures and pathological disease states. Mitochondrial GSH status 
is a critical determinant of cellular energetics and function and plays a critical role in 
determining susceptibility of cells to various toxicants. The ability to manipulate mitochondrial 
GSH status can provide a tool with which to probe mitochondrial function and modulate cellular 
injury upon exposure to various forms of mitochondrial toxicants. In this study, we used such an 
approach to alter one of the major GSH compartmentalization mechanisms in renal proximal 
tubules of the uninephrectomized rat model to produce protection from nephrotoxicants. Hence, 
further understanding of the regulation of mitochondrial GSH status and modulation of GSH 
levels in renal mitochondria hold promise for the development of new therapeutic approaches for 
many kidney diseases and chemically induced toxicities. 
 
The manipulation of mitochondrial GSH can also be used as a therapeutic target, not only for 
compensatory renal hypertrophy or in renal donors, but also for a number of diseases and 
pathological states that are associated with the depletion or oxidation of the mitochondrial GSH 
pool. For example, chronic ethanol ingestion and alcoholic liver disease are associated with 
decreased liver mitochondrial GSH content (Garcia-Ruiz et al., 1994, 1995; Fernandez-Checa et 
al., 1987, 1991, 1993, 2002), which also leads to an increase in susceptibility to toxicants (Zhao 
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and Slattery 2002; Zhao et al., 2002). Furthermore, cirrhosis and other forms of biliary 
obstruction have been associated with mitochondrial dysfunction caused by depletion of the 
matrix GSH pool (Krahenbuhl et al., 1992, 1995) and Type 2 diabetes has also been linked with 
depletion and oxidation of mitochondrial GSH in rat brain, heart and kidney (Santos et al., 2003; 
Mastrocola et al., 2005; Rosca et al., 2005), suggesting the importance of regulation of 
mitochondrial GSH. Clearly, it becomes apparent that it is important to design 
pharmacologically-based strategies aimed at specific targets in transport and catabolism of GSH 
as a potential therapeutic treatment against human kidney diseases, chemically induced toxicities 
and health complications in renal donors. Thus, reducing complications after nephrectomy will 
also directly increase the quality of life for a renal donor. 
 
Overall, the observations in this study enabled us to more completely define the phenotype for 
compensatory renal hypertrophy both in vivo and in an ex vivo model using primary culture of 
PT cells. This in turn also helped us to understand the biochemistry and toxicology of 
compensatory renal hypertrophy and provided a basis to reduce the risk of mitochondrial 
dysfunction and susceptibility to toxicants due to reduction in functional renal mass. With the 
basic knowledge acquired in this study, further studies of the protective effects of enhancing 
mitochondrial redox status and reversing deleterious properties of hypertrophied PT cells might 
provide a basis for novel therapeutic approaches to counteract the increased potential for renal 
insufficiency due to reduced functional renal mass. 
 
Future studies need to further explore the effect of overexpression of mitochondrial GSH 
transporters on oxidative stress, proliferation and cellular GSH status. Furthermore, it would be 
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interesting to examine a more comprehensive range of transporter expression and activity by also 
decreasing the expression and activity of the two mitochondrial GSH transporters, the DIC and 
OGC. 
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ABSTRACT 
 
COMPENSATROY RENAL HYPERTROPHY, MITOCHONDRIA AND REDOX 
STATUS 
by 
BAVNEET BENIPAL 
December 2011 
Advisor: Dr. Lawrence H. Lash 
Major: Pharmacology 
Degree: Doctor of Philosophy 
A reduction in functional renal mass occurs in humans during aging and severe kidney 
damage from diseases, injuries, infections and congenital conditions and after nephrectomy. 
Nephrectomy, or surgical removal of a kidney or a section of a kidney, is performed for 
treatment of unilateral secondary renal cancer, infections and for kidney transplantation. As a 
result, the remaining renal tissue undergoes compensatory growth due primarily to hypertrophy, 
in which both the size and functional capacity of the remaining kidney are increased. Renal 
compensatory hypertrophy is associated with a series of physiological, morphological and 
biochemical changes that also have toxicological implications. 
Previous studies have shown that compensatory renal cellular hypertrophy after 
uninephrectomy resulted in a hypermetabolic state, increased glutathione (GSH) content, but 
higher renal oxidative stress. These changes are also associated with increased susceptibility of 
renal proximal tubule cells to several drugs and environmental chemicals. Furthermore, our lab 
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also showed that overexpression of mitochondrial GSH transporters, the dicarboxylate (DIC, 
Slc25a10) and 2-oxoglutarate (OGC, Slc25a11) carriers, in NRK-52E cells, which are derived 
from normal rat kidney proximal tubules, exhibited increased mitochondrial GSH uptake, 
contents of GSH and protection from chemically induced apoptosis from exposure to 
nephrotoxicants. 
Based on these previous observations, we hypothesized that compensatory renal 
hypertrophy after uninephrectomy alters renal function in vivo and mitochondrial status and 
modulation of mitochondrial redox status alters susceptibility to nephrotoxicants in the remnant 
kidney. In this study, we used a uninephrectomized (NPX) rat model to induce compensatory 
renal growth. Our results show alterations in renal physiological parameters consistent with 
modest renal injury, altered renal cellular energetics, upregulation of certain renal plasma 
membrane transporters, including some that have been observed to transport GSH, and evidence 
of increased oxidative stress in mitochondria from the remnant kidney of NPX rats. Our present 
results provide further evidence that compensatory renal hypertrophy is associated with 
mitochondrial hypertrophy and hyperpolarization and manipulation of mitochondrial GSH 
transporters in PT cells of hypertrophied kidney alters susceptibility to chemically induced 
injury. These studies provide additional insight into the molecular changes that occur in 
compensatory renal hypertrophy and should help in the development of novel therapeutic 
approaches for patients with reduced renal mass. 
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